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INFLUENCE OF PUBLIC INSURANCE ON HEALTHCARE ACCESS AND CANCER 
CARE 
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Virginia Commonwealth University, 2016 
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Assistant Professor, Department of Health Behavior and Policy 
 
 
Medicaid expansion under the Affordable Care Act (ACA) facilitates access to care 
among vulnerable populations, but 21 states have not yet expanded the program. Tennessee’s 
Medicaid program experienced a dramatic Medicaid contraction when the program disenrolled 
approximately 170,000 nonelderly adults in 2005. Pre-ACA expansions were associated with 
better access to and utilization of healthcare services. However, little is known about the effect of 
these policy changes on improvement in health outcomes for women diagnosed with breast 
 
 
 
cancer, access to care for cancer survivors, and the effect of generosity and duration of expansion 
on access to care. 
This dissertation has three objectives. First, to assess the effects of the Tennesse’s 
Medicaid disenrollment on stage at diagnosis and delay in surgery for breast cancer among 
nonelderly women. Second, to compare access to care between cancer survivors living in non-
expansion states and survivors living in expansion states. Third, to examine the effect of 
generosity and duration of the pre-ACA Medicaid expansions on access to and utilization of 
healthcare services. 
I use three different types of datasets: the 2002-2008 data from Tennessee Cancer 
Registry, the 2012 and 2013 Behavioral Risk Factor Surveillance System (BRFSS), and the 2012 
Medical Expenditure Panel Survey (MEPS) data. I estimate difference-in-difference models and 
perform multiple logistic regression models to examine the impact of these policy changes on the 
different measurement outcomes. 
While many states are expanding Medicaid eligibility under the Affordable Care Act, 
there has been discussion among policymakers in some states about reducing eligibility under the 
Affordable Care Act once full federal funding expires. This study suggests that Medicaid 
disenrollment leads to later stage at diagnosis for breast cancer patients, indicating negative 
health impacts of contractions in Medicaid coverage. Prior to the passage of the Affordable Care 
Act, cancer survivors living in expansion states had better access to care than survivors living in 
non-expansion states. Failure to expand Medicaid could potentially leave many cancer survivors 
without access to routine care. The study informs policy makers that, relative to no expansion, 
 
 
 
moderate or generous expansion is associated with improvement in access to and utilization of 
healthcare services.  
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Chapter 1: Introduction 
 
Specific Aims 
Delay in access to preventive services is a barrier to get early diagnosis and treatment, 
and it has been shown to be associated with several complications (Weissman, Stern, Fielding, & 
Epstein, 1991). In contrast, timely access to preventive services improves health outcomes and 
increases quality of life (Healthy People 2020, 2014). 
The U.S. Preventive Services Task Force (USPSTF) guidelines recommend that women, 
50 – 74 years old receive biennial mammography screening to help detect breast cancer early and 
allow for timely treatment. Further, the Institute of Medicine (IOM) and the American Cancer 
Society (ACS) recommend that cancer survivors receive a survivorship care plan developed by 
their clinicians to facilitate follow-up care. The goal of these recommendations is to reduce the 
burden of cancer for patients and society. 
This dissertation examines two contradictory changes in the Medicaid program, both of 
which provide policy implications for Medicaid expansion under the Affordable Care Act and 
Medicaid policy moving forward. The first change is related to the 2005 Medicaid disenrollment 
in Tennessee and its impact on stage at diagnosis and treatment of female breast cancer. The 
second change is related to Medicaid expansion and its potential impact on access to and 
utilization of healthcare services among low-income people in general and cancer survivors in 
particular. 
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In the literature, Medicaid contractions have received less consideration than Medicaid 
expansions. Examining the effects of these contractions on health outcomes of low-income 
individuals who lose Medicaid coverage contributes to existing literature and provides evidence 
on consequences of these contractions. The first study of this dissertation examines the effects of 
Medicaid contraction in Tennessee on stage at diagnosis and delay in treatment of breast cancer 
among women living in low-income zip codes and those living in high-income zip codes. 
Medicaid expansion under the Affordable Care Act (ACA) aims to reduce the 
uninsurance rate and improve access to underserved populations (Department of Health and 
Human Services, 2014). Despite the anticipated benefits and the federal funding of Medicaid 
expansion, many states have decided not to expand their programs at this time. A baseline 
comparison between the two groups of states can shed light on the potential effects of state 
decisions whether to implement the expansion.  The second study of this dissertation examines 
baseline differences in access to healthcare services among cancer survivors living in states that 
expanded Medicaid, compared to survivors living in states that did not expand Medicaid as of 
June, 2015.  
 The literature suggests that Medicaid coverage provides enrollees with better health care 
access and outcomes (Coughlin, Long, & Shen, 2005; Long, Coughlin, & King, 2005). However, 
each state has its own rules to regulate and manage the program. Hence, experiences from each 
state can provide lessons for other states and federal level policies. The third study of this 
dissertation compares access to and utilization of healthcare services for low-income individuals 
living in states with generous Medicaid expansion, moderate expansion, and no expansion as of 
2012. The study also examines the effect of generosity and duration of expansion on access to 
and utilization of healthcare services among low-income individuals. 
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We have the following specific aims: 
Aim 1: Examine the effect of Tennessee’s Medicaid disenrollment on breast cancer stage at 
diagnosis and treatment among women living in low-income zip codes and those living in 
high-income zip codes. 
H1: After disenrollment, women living in low-income zip codes who were diagnosed with breast 
cancer had later stage of disease than women living in high-income zip codes. 
H2: After disenrollment, women living in low-income zip codes had greater delays in breast 
cancer treatment than women living in high-income zip codes. 
H3: After disenrollment, women living in Tennessee who were diagnosed with breast cancer had 
later stage of disease than women living in SEER states. 
Aim 2: Examine access to care for cancer survivors living in states that did not expand 
Medicaid and those living in states that expanded Medicaid. 
H1: Cancer survivors living in non-expansion states are more likely to be unable to see a doctor 
because of cost than survivors living in expansion states. 
H2: Cancer survivors living in non-expansion states are less likely to have a personal doctor and 
receive an annual checkup than survivors living in expansion states. 
Aim 3: Examine the effect of generosity and duration of Medicaid expansions on access to 
and utilization of preventive services among low-income adults 
H1: Low-income individuals living in states with generous or moderate expansion are more 
likely to have better access to and utilization of health services than low-income individuals 
living in no-expansion states. 
H2: Low-income individuals living in states with longer durations of expansion are more likely 
to have better access to healthcare services than a similar group of individuals living in no-
expansion states. 
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Conceptual Framework 
The three papers are related to policy changes in Medicaid eligibility, therefore they share 
the same conceptual model of healthcare services utilization. As shown in Figure 1, Andersen’s 
(1995) Behavioral Model of Health Services Use suggests that utilization of healthcare services 
is affected by three types of characteristics: predisposing, need, and enabling (Aday & Andersen, 
1974; Andersen, 1995). Predisposing characteristics describe individual’s tendency to use 
healthcare services. Predisposing characteristics include demographic characteristics, such as 
age, gender, race, and ethnicity. Need characteristics describe an individual’s health status or the 
main reason of seeking care from a healthcare provider. Enabling characteristics describe an 
individual’s resources that can be used to utilize healthcare services. This includes income and 
health insurance, which facilitate access to care. 
The characteristics from the model that are most central to the studies in this dissertation 
are the enabling characteristics. The model suggests that change in an individual’s health 
insurance coverage status can affect financial ability and affordability of care, and hence 
utilization of healthcare services. Individuals who lose health insurance coverage through 
Medicaid disenrollment are more likely to face a financial burden to access care and thus use 
fewer services. On the other hand, individuals who gain health insurance coverage as a result of 
Medicaid expansion are more likely to access care and use healthcare services than other people 
without insurance coverage. 
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Figure 1: Theoretical Framework of Healthcare Access and Utilization 
 
Scope and Approach 
This study will use secondary datasets to test the hypotheses. To answer the first set of 
questions, I use the 2002– 2008 Tennessee Cancer Registry data, Surveillance, Epidemiology, 
and End Results data, and income data from the Population Studies Center at University of 
Michigan. I estimate a difference-in-difference model to examine the association between 
Medicaid disenrollment and stage at diagnosis and delay in treatment. I use the 2012 and 2013 
data from the Behavioral Risk Factor Surveillance System and logistic regression models to 
answer the second set of questions and examine the association between Medicaid expansion and 
access to care among cancer survivors living in non-expansion states compared to those living in 
expansion states. To answer the third set of questions, I use the 2012 restricted Medical 
Expenditure Panel Survey data and estimate logistic regression models to examine the effect of 
 
 
 
 
 
 
  
 
 
Source: Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter. 
Journal of Health and Social Behavior 1995;36:1-8 
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generosity and duration of Medicaid expansions on access to and utilization of healthcare 
services. 
Significance of the Study 
The population of interest is low-income individuals who either lost or gained Medicaid 
coverage as a result of a state policy change. Compared with others, poor patients are at higher 
risk for delay in obtaining care because of cost (Weissman et al., 1991). People who lose 
Medicaid coverage are more likely to report unmet health care needs and experience increases in 
emergency department visits and hospitalization than those with continuous insurance (Carlson, 
DeVoe, & Wright, 2006; Emerson et al., 2012; Lowe, McConnell, Vogt, & Smith, 2008a). On 
the other hand, gaining Medicaid coverage may facilitate access to care and allow for utilization 
of healthcare services. However, generosity and duration of Medicaid programs may play an 
important role in deciding eligibility of low-income individuals across states. 
Although most of the current research focuses on Medicaid expansion, few studies have 
looked at consequences of Medicaid disenrollment. No research has examined the impact of the 
largest disenrollment, which occurred in Tennessee, on breast cancer diagnosis and treatment. In 
addition, previous studies did not compare access to care among cancer survivors living in non-
expansion states to those living in expansion states. Previous studies did not examine the 
association between generosity and duration of Medicaid on access to and utilization of 
healthcare services. 
This dissertation addresses important gaps in our knowledge about the impact of 
Medicaid disenrollment on stage at diagnosis and delay of treatment among the underserved 
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women. In addition, the study examines the impact of Medicaid policy changes on access to care 
among underserved populations. 
Summary of Remaining Chapters  
This chapter provided an overview of the study’s specific aims, conceptual framework, 
and analytical approach. The remainder of this dissertation proceeds as follows. Chapter 2 
focuses on the effects of Medicaid disenrollment in Tennessee on disparities in stage at diagnosis 
and surgery for female breast cancer. Chapter 3 provides a baseline overview on Medicaid 
expansion and access to care among cancer survivors. Chapter 4 presents the impact of 
generosity and duration of Medicaid expansion on access to healthcare services. Chapter 5 
summarizes conclusions and implications.
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Chapter 2: Paper I 
 
Medicaid disenrollment in Tennessee and disparities in stage at diagnosis and surgery for 
female breast cancer 
Abstract 
Purpose: To assess the effects of Medicaid disenrollment on stage at diagnosis and delay in 
surgery and treatment for female breast cancer among nonelderly women.  
Background: Although Medicaid expansions have received considerable attention in the 
literature, Medicaid contractions have received much less attention. Tennessee’s Medicaid 
program experienced a dramatic Medicaid contraction when the program disenrolled 
approximately 170,000 nonelderly adults after implementing a new benefit policy in 2005. 
Despite the fact that this was the largest disenrollment in the history of Medicaid, little is known 
about the effects of this policy change on access to care and health outcomes. This is the first 
study, to our knowledge, to consider the effect of disenrollment on stage at diagnosis and delay 
in surgery and treatment for breast cancer. 
Methods: We use 2002-2008 data from Tennessee Cancer Registry which collects data on newly 
diagnosed cases of malignant disease that occur to Tennessee residents from all hospitals, 
laboratories, facilities and healthcare practitioners. The sample used for this study consists of 
women aged 21 to 64 who were diagnosed with breast cancer and living in Tennessee during the 
period of study. We calculate the changes in stage at diagnosis, more than 60-days delay in 
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surgery, and more than 90-days delay in surgery for female breast cancer among women who 
were diagnosed with breast cancer and had surgery as the first-line treatment. We also calculate 
the changes in more than 60 and 90 days delay in treatment for patients for whom surgery was 
not the first-line treatment. We estimate a difference-in-difference model comparing women who 
were living in low-income zip codes (and thus more likely to be subject to disenrollment) with 
women who lived in high-income zip codes before and after Tennessee’s 2005 Medicaid 
disenrollment. We control for age, race/ethnicity, and marital status. 
Results: Overall, nonelderly women in TN were diagnosed at later stages and experienced more 
delays in treatment in the period after disenrollment. Women who lived in low-income zip codes 
were 3.3 percentage points (p < 0.05) more likely to be diagnosed with late stage (regional or 
distant) breast cancer, compared to women living in high-income zip codes, after Tennessee’s 
Medicaid disenrollment. In addition, nonelderly women who lived in low-income zip codes were 
1.9 percentage points (p < 0.05) less likely to have more than 60-days delay in surgery than 
women living in high-income zip codes, after the disenrollment. Women who lived in low-
income zip codes were also 1.4 percentage points (p <0.1) less likely to have more than 90-days 
delay in treatment. 
Conclusions: While many states are expanding Medicaid eligibility under the Affordable Care 
Act, there has been discussion among policymakers in some states to reduce eligibility once full 
federal funding expires. Our results suggest that Medicaid disenrollment leads to later stage at 
diagnosis for breast cancer patients, indicating negative health impacts of contractions in 
Medicaid coverage.  
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In 2005, Tennessee experienced the largest disenrollment in the history of Medicaid. The 
program disenrolled almost 170,000 participants and terminated their coverage (Bonnyman, 
2007; Chang CF & Steinberg SC., 2009). The disenrollment left these patients without health 
coverage that enables access to healthcare services, including breast cancer screening and 
treatment.  
Breast cancer is the second leading cause of cancer death among women. The American 
Cancer Society (ACS) estimates that 12% of women in the U.S. will develop breast cancer 
during their life (American Cancer Society, 2014b). Detection of breast cancer at early stage is 
associated with longer survival rate than detection at advanced stages. The 5- year relative 
survival rate for localized breast cancer is 98.5%, but it is 25% for distant stage (Surveillance, 
Epidemiology, and End Results Program, 2014). At the same time, early treatment is an 
important element in saving patients’ lives. A study, with a median follow-up period of 4.7 
years, found that waiting 60 days or more in initiating treatment was associated with significant 
increase in both overall and breast cancer related mortalities by 66% and 85%, respectively 
(McLaughlin et al., 2012). To encourage early detection of the disease, the U.S. Preventive 
Services Task Force recommends that women ages 50 to 74 receive a mammogram every 2 years 
(U.S. Preventive Services Task Force, 2010). Further, the American Cancer Society guidelines 
for breast cancer screening recommend annual mammograms starting at age 40 without 
restricting the screening to an upper age limit (American Cancer Society, 2014a).  
Disenrollment from a public health insurance coverage program has the potential to 
reduce patients’ ability to utilize health care services, including mammograms and breast cancer 
treatment. Research on Oregon and Arizona has provided evidence on the effect of Medicaid 
disenrollment on utilization of healthcare services. In 2003, many Medicaid enrollees lost their 
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coverage in Oregon due to implementation of cost saving strategies, including cost sharing, 
benefit reductions, and tightening of enrollment rules (Carlson et al., 2006). The individuals who 
lost coverage were more likely to report unmet health care needs and medical debt than 
individuals who did not lose their coverage. The newly disenrolled people were less likely to 
report having a primary care visit. Medicaid disenrollment of approximately 10% of children 
from the Medicaid/ State Children’s Health Insurance program in Arizona in 2004 was 
associated with reduction in ambulatory visits, and increases in emergency department visits and 
hospitalization (Rimsza, Butler, & Johnson, 2007).              
Although Tennessee had the largest disenrollment in the history of Medicaid, little 
research has examined the effects of this disenrollment in particular. A few studies examined the 
impact of termination of coverage for Medicaid enrollees on utilization of emergency room 
visits. Evidence shows that Medicaid disenrollment in Tennessee resulted in a significant 
increase in emergency department visits by the uninsured (Heavrin, Fu, Han, Storrow, & Lowe, 
2011). In their study of the impact of the disenrollment on avoidable hospital visits in Davidson 
County in Tennessee, Emerson et al. find an increased utilization of the emergency department 
by patients who became uninsured (Emerson et al., 2012). While these studies suggest that 
Medicaid disenrollment played a significant role in increasing utilization of emergency room 
visits, limited evidence exists on the effect of the policy change on cancer prevention, treatment 
and outcomes. 
 
Background 
Tennessee Medicaid Program (TennCare) 
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In 1994, Tennessee expanded its Medicaid program by creating TennCare to cover the 
uninsured (those with no insurance) and uninsurable (those who needed medical care, but their 
coverage was denied from insurers) adults and children (Centers of Medicare and Medicaid, 
2014; Gallen, 2014; Moreno & Hoag, 2001). The state enrolled all Medicaid participants in 
managed care plans and used the planned savings from the managed care plans in funding the 
expansion (Garthwaite, Gross, & Notowidigdo, 2014). Compared to other states, coverage under 
the 1994 health reform in Tennessee was very generous (Moreno & Hoag, 2001). Tennessee had 
three types of Medicaid coverage: (a) mandatory by the federal government, covering poor 
children, parents, and pregnant women; (b) optional by the state, covering children and pregnant 
women with higher income levels than the mandatory coverage; and (c) expansion 
(demonstration or Section 1115 waivers), covering the uninsured, uninsurable, and medically 
needy spend down individuals (Gallen, 2014). The latter category is defined as people who reach 
poverty when their medical expenditures are considered (Gallen, 2014). 
In 2002, Tennessee initiated TennCare II under another Section 1115 waiver, however, 
the program continued to face financial difficulties (Bureau of TennCare, 2005). In 2005, 
Tennessee was allowed to terminate optional and expansion enrollees from TennCare II, under a 
waiver amendment (Coughlin & Zuckerman, 2008). According to TennCare, the goal of this 
reform was to close certain eligibility categories, which included individuals ineligible for 
Medicaid (Bureau of TennCare, 2005). The disenrollment started in August 2005, and resulted in 
termination of approximately 200,000 adults (categorized as uninsured, medically eligible, non-
pregnant medically needy) from Medicaid (Bureau of TennCare, 2005). The disenrolled 
individuals represented 9.8 percent of the overall Medicaid population in that year. Had the same 
level of disenrollment occurred in all the states, the U.S could have experienced a larger drop in 
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overall insurance coverage nationally than during the Great recession of 2008 when millions of 
people lost their insurance coverage (Garthwaite et al., 2014). 
TennCareII Coverage and Take-up Rates 
TennCareII covered many categories, including children, pregnant women, and people 
with disabilities (Bureau of TennCare, 2006). In 2005, 23 percent of the Tennessee population 
was enrolled in TennCareII (Bureau of TennCare, 2005). The enrollment dropped to 20 percent 
of the population in 2006 (Bureau of TennCare, 2006). The number of enrollees dropped from 
1,336,691 in 2005 to 1,171,947 in 2006 (Bureau of TennCare, 2006). The disenrolled individuals 
were mostly uninsured and un-insurables.  
TennCare II covered many services, including inpatient, outpatient, pharmacy, lab, 
medical supplies, physician services, and reconstructive breast surgery (Bureau of TennCare, 
2005). The program offered the same benefits for all enrollees and did not require low-income 
people with incomes 100% of the federal poverty level (FPL) or below to pay premiums or co-
payments (Gallen, 2014). Among individuals with income below the poverty level, the take-up 
rate of Medicaid was 71 percent, which is 19 percentage points higher than the national take-up 
rate in 2002 (Gallen, 2014; Kaiser Family Foundataion Medicaid and the Uninsured, 2005). 
 Previous cross-sectional studies suggest that health insurance coverage is an important 
factor to reduce delays in diagnosis and improve health outcomes among women diagnosed with 
breast cancer (Halpern, Bian, Ward, Schrag, & Chen, 2007; McDavid, Tucker, Sloggett, & 
Coleman, 2003; Smith et al., 2013). Further, studies on Medicaid disenrollment in different states 
found that termination of coverage was high among vulnerable populations, and that it increased 
utilization of the emergency department (Emerson et al., 2012; Lowe, McConnell, Vogt, & 
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Smith, 2008b; Wallace, Mcconnell, Gallia, & Edlund, 2010) and caused discontinuity of care 
(Weissman, Witzburg, Linov, & Campbell, 1999). In their study, Emerson et al used a logistic 
model to examine the effect of Medicaid disenrollment on number of emergency room visits. 
They found that the number of emergency room visits by the uninsured significantly increased 
by 18 percentage points. However, the study was limited to only one county in Tennessee 
(Emerson et al., 2012). A study documented an increase in number of emergency room visits by 
the uninsured as a result of reducing the Medicaid budget in Oregon. Although the study used 
two years before and two years after the policy change, it could not conclude whether the higher 
number of visits was related to the same patients using more services or an increase in the 
number of uninsured due to disenrollment (Lowe et al., 2008b). The question remains what the 
impact of loss of Medicaid coverage in Tennessee on healthcare outcomes is and, in particular, 
on cancer related outcomes such as diagnosis and treatment. 
In this study, we provide evidence on the impact of Medicaid disenrollment in Tennessee 
on timely access to breast cancer screening and treatment. Specifically, we examine the impact 
of the 2005 Medicaid disenrollment in Tennessee on delays in diagnosis and treatment of breast 
cancer. We use a quasi-experimental method to examine whether Medicaid disenrollment is 
associated with delays in diagnosis and treatment of breast cancer. Because cross sectional 
studies are more likely to suffer from omitted variable bias and thus cannot estimate the causal 
relationship between changes in insurance coverage and healthcare related outcomes, we 
examine the impact of arguably exogenous Medicaid disenrollment on breast cancer diagnosis 
and treatment by using data from the Tennessee Cancer Registry and applying a difference in 
difference model. 
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Data 
The data were obtained from the Tennessee Cancer Registry (TCR), a population-based 
cancer registry that collects information on Tennessee residents diagnosed with and/or treated for 
cancer (Tennessee Department of Health, 2014). TCR collects comprehensive and timely data 
from all hospitals, laboratories, facilities and healthcare practitioners. The data include 
information on incidence, stage at diagnosis, treatment, and vital status. The TCR data have met 
national standards of data completeness and quality since 2004 (silver standard in 2004 and gold 
standard subsequently).1 The data on primary payer at diagnosis, however, may not reflect the 
actual payer, and thus are not reliable for determining whether patients were actually covered by 
Medicaid.2 In addition, the registry did not begin to collect data on metastasis and lymph node 
involvement until 2004. 
In total, there were 74,292 observations for women who were diagnosed with female 
breast cancer during 2000 – 2010. We exclude 421 observations because they were diagnosed at 
death; 28,187 observations because they were younger than 21 or older than 64; and 215 
observations because they were missing both month and day of diagnosis (96 observations), of 
surgery (55 observations), or of treatment (64 observations). When dates of diagnosis, surgery, 
or treatment are missing days only, we assume that the missing day was the 15th of the month. In 
addition, we exclude 76 observations because date of surgery is before date of diagnosis, and 24 
observations because date of treatment is before date of diagnosis. Furthermore, we exclude 129 
and 38 observations when time to surgery or time to treatment exceeds 365, respectively. We 
                                                          
1 Source:  Martin Whiteside, DC, PhD, MSPH, Director, Office of Cancer Surveillance, Division of Policy, Planning 
& Assessment, Tennessee Department of Health 
2 http://www.naaccr.org/LinkClick.aspx?fileticket=AtR4s7_3i34%3D&tabid=230&mid=679 
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also exclude 595 observations because the zip codes in these observations were P.O. Box zip 
codes and may not represent the actual zip code of the patient’s residence.    
We merge the Tennessee Cancer Registry data with zip code median income data (2006-
2011 release) from the Population Studies Center at University of Michigan. Because we are 
interested in estimating the effect of the 2005 Medicaid disenrollment on women eligible for 
Medicaid, we restrict our sample to women between ages 21 and 64 who were diagnosed with 
breast cancer between 2002 and 2008. We use the three years before (2002 – 2004) and the three 
years after (2006 – 2008) Medicaid disenrollment. We exclude 2005 because Medicaid 
disenrollment occurred in that year. We use three samples to conduct our analyses: one for stage 
at diagnosis, one for delay in surgery (and time to surgery), and the third one for delay in 
treatment (and time to treatment). Our final sample for stage at diagnosis consists of 19,100 
observations with no missing data except for missing data on marital status.3 After conducting 
this analysis, we divide the sample into two subsamples: the first subsample contains 15,590 
observations that have surgery as first line of treatment (surgery only or surgery followed by 
adjuvant treatment) while the second subsample consists of 3,510 observations that had 
neoadjuvant therapy as first line of treatment. For the first sample, we exclude 366 observations 
that are diagnosed at distant stage because these observations do not usually receive surgery. We 
also exclude 1,690 observations that have localized or regional stage but have date of surgery of 
primary site the same as date of diagnosis (we assume these dates should only be the same if the 
case is in situ). Our final sample for the delay in surgery analyses consists of 13,534 
observations. Appendix I illustrates the exclusion criteria and final sample with a flow chart. 
                                                          
3 We chose not to exclude 601 observations with missing and unknown data on marital status to maximize our 
sample. 
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Outcome measures 
Our main dependent variable is stage at diagnosis, but we also consider variables related 
to delay in surgery and treatment to examine the patterns of change in these variables before and 
after the disenrollment. Therefore, we consider seven dependent variables: one variable for stage 
at diagnosis, two variables for delay in surgery, two variables for delay in treatment, one variable 
for time to surgery, and one variable for time to treatment. To define stage at diagnosis, we 
recode the variable that refers to the SEER Summary Stage into a binary variable that equals one 
for late diagnoses (regional or distant) and zero for early diagnoses (in situ or localized). For both 
delays in surgery and delays in treatment, we create two binary variables, the first indicating 
delay more than 60-days from date of diagnosis and the second indicating delay more than 90-
days. For both time to surgery and time to treatment, we use continuous variables representing 
the difference in days between date of surgery (or treatment) and date of diagnosis. Although 
date of most definitive surgery is considered more representative for date of surgery, this 
variable is missing for many of our observations. Hence, to construct the delays in surgery and 
time to surgery outcome variables, we define date of surgery to be the date of surgery of the 
primary site. However, we use date of most definitive surgery instead of date of surgery of 
primary site in particular situations: when date of surgery of primary site is the same as date of 
diagnosis (as it could be a diagnostic biopsy at the time of diagnosis; 2,215 observations), when 
surgery was a resection (23 observations), and when date of most definitive surgery is before 
date of surgery of primary site (because the second operation is likely the most definitive; 18 
observations). 
Statistical Analyses 
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We use three different statistical analyses. First, in our primary analysis, we estimate the 
following difference-in-difference model for each one of our outcomes: stage at diagnosis, delay 
in surgery, delay in treatment, time to surgery, and time to treatment. The difference-in-
difference model compares the outcomes for women who were living in low-income zip codes 
(and thus more likely to be subject to disenrollment) and women who were living in high-income 
zip codes before and after Tennessee’s 2005 Medicaid disenrollment. 
 
Yijt = β0 + β1 Low-incomej + β2 Postt + β3 (Low-incomej × Postt) + β4 Xijt + ϵijt                      (1) 
 
In the model, i indexes individuals, j indexes zip codes, and t indexes years. Low-incomej 
is a binary variable that is equal to one for women living in zip codes characterized by low-
income, and is equal to zero for individuals living in high-income zip codes.4 Postt is a binary 
variable for time and it is equal to one for the post-disenrollment years 2006–2008, and is equal 
to zero for the years 2002–2004. Xijt represents time-varying individual controls, including age at 
diagnosis, race, ethnicity, and marital status.5 ϵijt is the error term. The coefficient of primary 
interest is β3, on the Low-incomej × Postt interaction term, which captures the difference between 
the outcomes for women living in low-income and high-income zip codes before and after 
                                                          
4 We define low-income zip codes as those with median income less than or equal to $38,700 (the median income of 
200% FPL)  
5 We considered including stage at diagnosis, insurance status, education, and employment as covariates in our 
models, but we did not include any of them in the main analyses. While stage at diagnosis could affect delay in 
treatment, it can be endogenous if we think that having a bad doctor is associated with late stage at diagnosis. On the 
other hand, some researchers would argue that different doctors could have seen the same patients before and after 
disenrollment and hence stage at diagnosis will not be correlated with the error term. To deal with this argument, we 
excluded stage at diagnosis from the analyses, but repeated the primary analysis in equation 1 with inclusion of stage 
at diagnosis and obtained similar results. We chose not to include insurance status in the analyses because we are 
examining the effect of Medicaid disenrollment on our outcomes and wanted to avoid holding many factors constant 
in our models. However, we repeated the primary analysis including insurance and obtained similar results. We 
could not control for education or employment in our analyses because the registry data do not report level of 
education and more than 86% of observations were missing employment in the original data. 
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Medicaid disenrollment. We estimate linear probability models for ease of interpretation (Ai & 
Norton, 2003). 
Second, we use another control group for women who lived in Tennessee and were 
diagnosed with breast cancer. The control group comes from publicly available data from the 
Surveillance Epidemiology and End Results (SEER) database. SEER is a program of the 
National Cancer Institute (NCI) and it collects updated data on patient demographics, cancer 
incidence, survival, and treatment from population-based cancer registries. Including information 
on survival and stage of cancer at time of diagnosis makes the SEER data the only 
comprehensive cancer registry dataset on the population of the United States. The SEER 
program collects data from 18 registries: ten states, five metropolitan areas, and three Native 
American Registries. For this analysis, we use the following difference-in-difference model: 
 
Yit = β0 + β1 TNi + β2 Postt + β3 (TNi × Postt) + β4 Xit + ϵit ,                     (2) 
 
where i indexes individuals and t indexes years. TNi is a binary variable that is equal to one for 
women living in Tennessee, and is equal to zero for women living in the SEER states. 
 
Sensitivity Analyses 
We performed several sensitivity analyses to assess the robustness of our results. First, 
we did not exclude observations with localized or regional stage at diagnosis that had the same 
date for both diagnosis and surgery. Second, we repeated the delay in surgery analyses for the 
delay in surgery outcomes without replacing dates of surgery of primary site with date of most 
definitive surgery when date of surgery of primary site was the same as date of diagnosis. Third, 
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we repeated the analyses without replacing dates that have missing days in dates of diagnosis or 
surgery with the 15th of the month (observations with missing days are dropped in these 
analyses). Finally, we repeated the analyses restricting our sample to the years 2004 and 2006 
and controlling for metastasis and lymph node involvement, which are missing for 2002 and 
2003. 
 
Results  
Primary Analyses 
 
Table 1 shows the characteristics of the stage at diagnosis sample by disenrollment and 
zip code income. The sample consists of 19,100 women who lived in Tennessee between 2002 
and 2008 before and after the 2005 Medicaid disenrollment. Before Medicaid disenrollment, 
15.9% of the women in the sample lived in low-income zip codes, while 37.1% lived in high-
income zip codes after the disenrollment. The table shows that the number of cases diagnosed 
with distant stages increases in both low- and high-income zip codes after disenrollment. Women 
living in low-income zip codes before disenrollment had significantly higher delays in more than 
60 days surgery (difference = 1.83, p <0.001) and treatment (difference = 0.87, p = 0.03) than 
women living in high-income zip codes.  While both women living in low and high-income zip 
codes had longer delays in surgery and treatment after disenrollment, the delays for women 
living in high-income zip codes were higher. For example, more than 60 days delay in surgery 
significantly (p = 0.005) increased from 11.98% before disenrollment to 14.34% after 
disenrollment among women living in low-income zip codes while it significantly (p< 0.001) 
increased from 10.15% before disenrollment to 14.36% after disenrollment among women living 
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in high-income zip codes. The average age of women in the sample is 51 years, and more than 
60% are 50 – 64 years old. Most women in the sample are white, married, and insured. Before 
disenrollment, almost 80% of the women in our sample did not have any comorbidity, but 
comorbidities increased for women living in either type of zip code after disenrollment. 
Table 2 shows the results from the difference-in-difference models for all the outcome 
variables. Compared to women living in high-income zip codes, women living in low-income zip 
codes had a significant increase of 3.3 percentage points (p = 0.024) in the probability of being 
diagnosed at late stages (regional or distant) after the 2005 Tennessee Medicaid disenrollment. 
Women living in low-income zip codes had a significant decrease of 1.9 percentage points (p = 
.024) and 1.4 percentage points (p = .054) in the probabilities of more than 60 and 90 days delay 
in surgery and treatment, respectively, compared to women living in high-income zip codes. 
When we use the continuous variables, women living in low-income zip codes have a significant 
decrease of 2.4 days (p = .008) in time to surgery and of 2.8 days (p= .041) in time to treatment 
after disenrollment, compared to women living in high-income zip codes. Regardless of level of 
zip code income, all women living in Tennessee in our sample had significant or marginally 
significant delays in surgery and treatment (except for more than 90 days delay in treatment) 
after disenrollment.   
Using the control group consisting of women living in SEER states supports our results 
from the primary analysis considering stage at diagnosis. Table 3 shows the difference in 
difference results for this analysis. Compared to women living in SEER states, women living in 
Tennessee had a significant increase of 3.8 percentage points (p<.001) in the probability of being 
diagnosed at late stage. 
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Sensitivity Analyses 
When we did not exclude observations with localized or regional stage at diagnosis that 
had the same date for both diagnosis and surgery from the surgery sample, the coefficients were 
slightly lower than the coefficients in our primary analysis, but they were in the same direction. 
The coefficient from the model of more than 60 days delay in surgery decreased to – 1.5 
percentage points (compared with – 1.9 in the primary analysis) and remained significant (p = 
0.042) as shown in Table 4. The coefficient from the model of time to surgery also decreased by 
0.74 day and became slightly less significant (p = 0.044). Table 5 shows the results of the 
difference-in-difference model in which we did not replace dates of surgery of primary site with 
date of most definitive surgery when date of surgery of primary site was the same as date of 
diagnosis. The coefficients were similar for stage at diagnosis and delays in surgery and 
treatment, but lower and less significant for time to surgery and treatment.  Table 6 shows the 
results for the model in which we repeated the primary analyses without replacing dates of 
diagnosis or surgery that have missing days with the 15th of the month. The coefficient for stage 
at diagnosis increases slightly and becomes more significant (3.5 percentage points, p = 0.017) 
while coefficients for delay in surgery and treatment as well as time to surgery and treatment are 
similar to those in the primary analyses. Table 7 shows the coefficients for the model that only 
uses data from 2004, 2006 and controls for metastasis and lymph node involvement. While the 
coefficients for stage at diagnosis decreased slightly, the coefficients for more than 60 days delay 
in surgery and time to surgery increased and became insignificant (or less significant for time to 
surgery). The coefficient for more than 90 days delay in treatment increased and became more 
significant while the coefficient for time to treatment increased and became insignificant. In 
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summary, our results are robust to many changes in specific variable and sample definitions and 
model specifications. 
 
Discussion 
We examined the effect of the 2005 Medicaid disenrollment in Tennessee on disparities 
in stage at diagnosis, delay in surgery, and delay in treatment for female breast cancer. We found 
that Medicaid disenrollment was associated with worsening in diagnosis of breast cancer, but 
less delay in surgery or treatment for women living in low-income zip codes. Furthermore, we 
found that women living in Tennessee were diagnosed with breast cancer at later stage than 
women living in the SEER states. Our findings on stage at diagnosis were the most robust and in 
the expected direction. Women living in low-income zip codes are diagnosed at late stage of 
breast cancer because they do not have health insurance, which improves access to care and 
allows for timely access to healthcare services such as mammography screening. Although the 
National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in Tennessee 
provided free mammograms to uninsured and underinsured women who had income below 
250% FPL, the program, like similar programs across the country, could only reach twenty 
percent of eligible women on average (American Cancer Society, 2011; Tangka et al., 2010). 
Hence, many uninsured women were not able to receive regular mammograms.  
Our descriptive results show that women living in either low or high-income zip codes 
had delays in surgery and treatment after the disenrollment. High-income women have a smaller 
magnitude of delays in the pre-disenrollment period relative to women living in low-income zip 
codes and hence a larger increase in delays, though the reason for this pattern is unclear. 
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Although we hypothesized that women living in low-income zip codes will have greater delays 
in surgery and treatment than women living in high-income zip codes, our DD estimates suggest 
that women living in low-income zip codes had 2.4 and 2.8 fewer days of delays in surgery and 
treatment, respectively, than women living in high-income zip codes after disenrollment. Our 
results are consistent with results from previous research, which found that women living in the 
highest income quintiles were 1.47 times more likely to experience delay between diagnosis of 
breast cancer and surgery than women living in the lowest income quintile (Plotogea et al., 
2013). 
There are several ways to interpret our findings on late stage at diagnosis and fewer 
delays in surgery and treatment for low-income women. First, diagnosis of cancer depends on 
regular access to preventive services provided by a primary care physician not an oncologist. 
Low-income women who previously had Medicaid coverage but lost it because of the 
disenrollment, will most likely lose the possibility of access to preventive services such as 
mammography screening, which is an important tool to detect breast cancer in early stages. Once 
uninsured low-income women are diagnosed with breast cancer, they usually become covered by 
Medicaid through the Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA) and 
start their treatment as indicated by their oncologists (French, True, McIntyre, Sciulli, & Maloy, 
2004). In this way, low-income women who lost their Medicaid coverage are re-enrolled in 
Medicaid to receive cancer treatment (and other healthcare services) after being diagnosed with 
breast cancer. However, Medicaid coverage only after diagnosis with breast cancer is not helpful 
as continuous coverage beginning before diagnosis. A previous study highlighted the importance 
of Medicaid coverage before diagnosis by finding that uninsured women were two times more 
likely to be diagnosed with late stage breast cancer compared to women who were insured by 
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Medicaid in the same month of diagnosis (Bradley, Given, & Roberts, 2003). Second, women 
living in high-income zip codes are assumed to be more likely to have private insurance and thus 
be less affected by the disenrollment. Since these women have access to preventive care services, 
they are more likely to have regular mammography screenings, which detect cancer at an early 
stage. Once high-income women are diagnosed with breast cancer, they need to receive surgery 
or neoadjuvant therapy. Because these women have higher incomes, they may need extra time to 
schedule their appointments and begin treatment because they may choose to have plastic 
surgery,6 seek a second opinion from other oncologists, or even contact their health insurance 
plan to inquire about covered services. These factors and others may result in a few days of delay 
in surgery or treatment despite early diagnosis of the disease.   
Several limitations must be acknowledged. First, although this study can be generalized 
to the southern states, it is not possible to generalize it to the whole country. The states in this 
study are different from the rest of the U.S. in terms of demographics and un-insurance and 
poverty rates. Second, there is a difference in quality of the data requested from the Tennessee 
Cancer Registry before and after Medicaid disenrollment. The data requested have only met the 
national gold standards of data completeness and quality for the period 2004–2008. They have 
met the silver standards in 2004. Therefore, the difference in quality of the data may bias the 
estimates in the study. Third, although date of most definitive surgery is the most accurate date 
for surgery, this variable was missing for more than 40% of observations in the original dataset 
and we had to use date of surgery of primary site instead. Similarly, more than 35% of 
observations were missing date therapy initiated based on SEER, and we had to use dates from 
Commission on Cancer (CoC) instead. Fourth, the cancer registry data do not include reliable 
                                                          
6 Receiving plastic surgery is beyond the scope of this paper, but we will consider that in future research. 
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information on type of health insurance coverage or income, so we were not able to identify 
women with Medicaid coverage or low household incomes. To deal with that, we used living in a 
zip code with a particular median income as a proxy for income and Medicaid coverage. Fifth, 
we were not able to control for metastasis or lymph node involvement in our analyses because 
these variables were missing in 2002 and 2003. To control for these variables when it was 
possible, we conducted a restricted sensitivity analysis with 2004 represents pre-disenrollment 
and 2006 represents post-disenrollment and found that stage at diagnosis decreased slightly and 
time to surgery increased slightly but both became marginally significant. Sixth, there were 352 
observations for which date of diagnosis and 152 observations for which date of surgery of 
primary site were incomplete (missing day of the month). To deal with this issue, we considered 
the missing day to be the 15th of the month but conducted a sensitivity analysis without this 
consideration. Our results were similar to those in the primary analyses. Seventh, we were not 
able to control for level of education because the cancer registries do not collect data on 
education. Finally, we could not control for employment because more than 86% of the 
observations in the original sample were missing this information. 
Our findings may have important policy implications for states that may consider 
terminating coverage of new Medicaid enrollees under the ACA after expanding Medicaid for a 
few years. Medicaid expansion under the Affordable Care Act (ACA) increases the Medicaid 
eligibility threshold to 138% FPL, with the goal of reducing the uninsurance rate (Kaiser Family 
Foundation, 2014a). During the first three years of Medicaid expansion, the federal government 
is providing complete funding to cover new Medicaid enrollees (Center on Budget and Policy 
Priorities, 2012). Starting in the third year, 2017, the responsibility of funding the program will 
be shared gradually between the states and the federal government. Although the ACA was 
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written with the intent of expanding Medicaid in all states, the 2012 Supreme Court decision 
made it optional for states to expand Medicaid (Kaiser Family Foundation, 2012). As of August 
2015, 29 states and DC decided to expand Medicaid while the rest of the states did not expand 
the program (Kaiser Family Foundation, 2014b). In 2013, the Michigan House of 
Representatives approved the Medicaid expansion to enroll newly eligible adults in the program. 
However, it authorized Michigan to withdraw from the expansion in the event that the savings 
from the expansion do not offset Medicaid cost in 2017 or later (Ayanian, 2013). A decision such 
as this would lead to termination of coverage for many low-income people. The 2005 Medicaid 
disenrollment in Tennessee can provide several lessons to be learned in respect to access and 
utilization of preventive care services, and subsequent delays in diagnosis and treatment of 
diseases such as breast cancer, which has better prognosis when diagnosed early (American 
Cancer Society, 2014c). Our results indicate that losing Medicaid coverage has important health 
consequences for low-income patients subsequently diagnosed with cancer, and these health 
impacts should be considered by policymakers weighing the costs and benefits of implementing 
or continuing expanded Medicaid coverage under the ACA. 
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      Table 1: Descriptive statistics of the stage at diagnosis sample by disenrollment and income 
 Pre-disenrollment 
(n= 8,525) 
Post-disenrollment 
(n= 10,575) 
 Low-income 
zip codes 
(n= 3,028) 
High-income 
zip codes 
(n= 5,497) 
P Value Low-income 
zip codes 
(n= 3,486) 
High-income 
zip codes 
(n= 7,089) 
P Value 
Stage at diagnosis 
(%) 
      
  In situ 14.17 15.88 .02 14.95 18.07 <.001 
  Localized 50.43 49.48 44.89 45.69 
  Regional 32.79 32.80 36.66 32.59 
  Distant 2.61 1.84 3.50 3.65 
Delay in surgery_60 
days (%) 
11.99 10.15 .01 14.34 14.36 .98 
Delay in surgery_90 
days (%) 
8.88 7.70 .05 9.93 9.58 .57 
Delay in 
treatment_60 days 
(%) 
3.67 2.80 .03 5.57 5.98 .39 
Delay in 
treatment_90 days 
(%) 
1.59 1.24 .18 2.21 1.92 .32 
Age at diagnosis ± 
(SD) 
51.50±(8.57) 51.23±(8.36) .16 51.62±(8.23) 51.84±(8.27) .19 
Age (%)       
  21–39 years 10.11 9.61 .30 8.38 8.31 .83 
  40–49 years 27.41 28.92 29.49 28.96 
  50–64 years 62.48 61.47 62.13 62.73 
Race (%)       
  White 78.10 87.90 <.001 77.57 86.15 <.001 
  African American 21.47 10.57 21.80 12.08 
  Asian 0.26 0.98 0.37 1.38 
  Other 0.17 0.55 0.26 0.39 
Hispanic (%) 0.40 0.38 .92 0.69 0.49 .21 
Marital status (%)       
Married 62.45 70.66 <.001 59.84 69.08 <.001 
Unmarried 33.55 26.81 35.48 28.41 
Missing 4.00 2.53 4.68 2.51 
Insured (%) 98.35 98.85 .05 98.31 98.67 .14 
Comorbidities (%)       
  0 Comorbidity 80.28 78.75 .07 62.56 65.10 .03 
  1 Comorbidity 6.97 7.77 13.37 11.54 
  2 Comorbidities 3.90 4.93 7.77 7.56 
  3+ Comorbidities 8.85 8.55 16.29 15.80 
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Table 2: Results of the difference-in-difference model (Primary analysis)  
 Stage at 
diagnosis 
>60 days 
delay in 
surgery 
>90 days 
delay in 
surgery 
>60 days 
delay in 
treatment 
>90 days 
delay in 
treatmen
t 
Time to 
surgery 
(days) 
Time to 
treatment 
(days) 
Observations 19,100 13,534 13,534 3,510 3,510 13,534 3,510 
Low-
income_Post 
0.033** 
(0.024) 
-0.019** 
(0.024) 
-0.000 
(0.957) 
-0.009 
(0.410) 
-0.014* 
(0.054) 
-
2.442*** 
(0.008) 
-2.815** 
(0.041) 
Low-income -0.002 
(0.833) 
0.013** 
(0.039) 
0.002 
(0.611) 
0.002 
(0.807) 
0.012** 
(0.026) 
1.724** 
(0.014) 
0.732 
(0.460) 
Post 0.017* 
(0.055) 
0.031*** 
(0.000) 
0.005* 
(0.078) 
0.020*** 
(0.003) 
0.007 
(0.100) 
6.043*** 
(0.000) 
6.943*** 
(0.000) 
40-49 years -0.095*** 
(0.000) 
0.003 
(0.675) 
-0.001 
(0.803) 
0.001 
(0.881) 
0.005 
(0.391) 
0.287 
(0.741) 
-0.961 
(0.385) 
50-64 years -0.145*** 
(0.000) 
-0.000 
(0.996) 
-0.002 
(0.614) 
-0.007 
(0.374) 
-0.001 
(0.867) 
0.349 
(0.670) 
-2.043** 
(0.050) 
African 
American 
0.077*** 
(0.000) 
0.046*** 
(0.000) 
0.034*** 
(0.000) 
0.032*** 
(0.000) 
0.020**
* 
(0.000) 
5.665*** 
(0.000) 
6.655*** 
(0.000) 
Asian 0.095*** 
(0.009) 
0.031 
(0.135) 
0.026** 
(0.035) 
-0.025 
(0.398) 
-0.007 
(0.730) 
3.129 
(0.165) 
1.902 
(0.621) 
Other race 0.033 
(0.561) 
-0.035 
(0.262) 
0.005 
(0.808) 
-0.031 
(0.652) 
-0.009 
(0.850) 
-1.636 
(0.630) 
13.311 
(0.134) 
Hispanic 0.003 
(0.950) 
0.059* 
(0.057) 
-0.000 
(0.984) 
0.175*** 
(0.000) 
0.194**
* 
(0.000) 
6.980** 
(0.040) 
17.220*** 
(0.001) 
Married -0.029*** 
(0.000) 
-
0.014*** 
(0.002) 
-0.001 
(0.607) 
-0.007 
(0.232) 
-0.004 
(0.365) 
-
1.349*** 
(0.006) 
-3.270*** 
(0.000) 
Married_missin
g 
-0.031 
(0.126) 
-0.009 
(0.453) 
0.006 
(0.437) 
-0.001 
(0.962) 
0.016 
(0.162) 
-
3.761*** 
(0.003) 
-0.109 
(0.959) 
1 Comorbidity -0.027** 
(0.020) 
0.024*** 
(0.000) 
0.009** 
(0.033) 
0.001 
(0.950) 
0.009 
(0.131) 
1.841** 
(0.011) 
-1.791 
(0.101) 
2 Comorbidities -0.019 
(0.185) 
0.002 
(0.775) 
0.002 
(0.648) 
-0.009 
(0.408) 
0.004 
(0.563) 
0.009 
(0.992) 
-1.498 
(0.273) 
3+ 
Comorbidities  
0.012 
(0.259) 
0.020*** 
(0.001) 
0.008** 
(0.031) 
-0.010 
(0.189) 
-0.002 
(0.730) 
1.743*** 
(0.008) 
-1.741* 
(0.089) 
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Table 3: Results of the difference-in-difference model (using SEER states as the control group) 
 Stage at 
diagnosis 
Observations 240,598 
TN_Post 0.038*** 
(0.000) 
TN 0.029*** 
(0.000) 
Post -0.013*** 
(0.000) 
40-49 years -0.120*** 
(0.000) 
50-64 years -0.147*** 
(0.000) 
African 
American 
0.078*** 
(0.000) 
Asian -0.012*** 
(0.002) 
Other race 0.027*** 
(0.003) 
Hispanic 0.066*** 
(0.000) 
Married -0.034*** 
(0.000) 
Married_missing -0.055*** 
(0.000) 
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Sensitivity analyses: 
 
Table 4: Results of the difference-in-difference model (including localized, and regional but include 
observations that have the same date for surgery and diagnosis) 
Note: The results of stage at diagnosis and delays in treatment are not affected by this (it only affects 
delays in surgery) 
 >60 days delay in 
surgery 
>90 days delay in surgery Time to surgery 
(days) 
Observations 15,224 15,224 15,224 
Low-income_Post -0.015** 
(0.042) 
0.001 
(0.882) 
-1.737** 
(0.044) 
Low-income 0.009 
(0.103) 
0.001 
(0.841) 
0.683 
(0.288) 
Post 0.030*** 
(0.000) 
0.006** 
(0.030) 
7.131*** 
(0.000) 
 
 
Table 5: Results of the difference-in-difference model (No replacement for dates of surgery of primary 
site with date of most definitive surgery when date of surgery of primary site is the same as date of 
diagnosis) 
 Stage at 
diagnosis 
>60 days 
delay in 
surgery 
>90 
days 
delay in 
surgery 
>60 days 
delay in 
treatment 
>90 days 
delay in 
treatment 
Time to 
surgery 
(days) 
Time to 
treatment 
(days) 
Observations 19,104 14,055 14,055 2,215 2,215 14,055 2,215 
Low-
income_Post 
0.033** 
(0.023) 
-0.018** 
(0.028) 
0.001 
(0.831) 
-0.010 
(0.541) 
-0.020* 
(0.083) 
-2.088** 
(0.025) 
-2.568 
(0.183) 
Low-income -0.002 
(0.825) 
0.010 
(0.101) 
-0.000 
(0.941) 
-0.001 
(0.940) 
0.016* 
(0.051) 
1.421** 
(0.045) 
-0.873 
(0.531) 
Post 0.016* 
(0.057) 
0.031*** 
(0.000) 
0.005 
(0.116) 
0.027** 
(0.012) 
0.010 
(0.167) 
6.073*** 
(0.000) 
8.761*** 
(0.000) 
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Table 6: Results of the difference-in-difference model (No replacement of missing day of date of 
diagnosis or surgery with the 15th of the month) 
 Stage at 
diagnosi
s 
>60 days 
delay in 
surgery 
>90 days 
delay in 
surgery 
>60 days 
delay in 
treatment 
>90 days 
delay in 
treatment 
Time to 
surgery 
(days) 
Time to 
treatmen
t (days) 
Observation
s 
18,907 13,450 13,450 3,412 3,412 13,450 3,412 
Low-
income_Post 
0.035** 
(0.017) 
-0.019** 
(0.022) 
-0.000 
(0.923) 
-0.017 
(0.102) 
-0.014** 
(0.044) 
-
2.452*** 
(0.007) 
-2.937** 
(0.029) 
Low-income -0.002 
(0.882) 
0.013** 
(0.036) 
0.002 
(0.572) 
0.000 
(0.976) 
0.009** 
(0.071) 
1.713** 
(0.013) 
0.362 
(0.706) 
Post 0.015* 
(0.085) 
0.032*** 
(0.000) 
0.006** 
(0.033) 
0.021*** 
(0.001) 
0.008* 
(0.072) 
6.214*** 
(0.000) 
6.696*** 
(0.000) 
 
 
Table 7: Results of the difference-in-difference model (Using 2004 as pre- and 2006 as post-disenrollment 
and controlling for lymph nodes involvement and metastasis) 
 Stage_D
x 
Delay_su
rg_60 
Delay_su
rg_90 
Delay_ttt
_60 
Delay_ttt_
90 
Delay_sur
g_cont 
Delay_ttt_c
ont 
Observations 5,807 4,442 4,442 1,245 1,245 4,442 1,245 
low_income_2
00_Post2 
0.027*  
(0.025) 
0.002 
(0.902) 
0.002 
(0.807) 
0.003 
(0.853) 
-0.020*** 
(0.049) 
-2.674* 
( 0.096) 
-3.055 
(0.107) 
low_income_2
00 
-0.003 
(0.703) 
-0.005 
(0.611) 
-0.006 
(0.373) 
-0.004 
(0.736) 
0.015** 
(0.041) 
0.699 
(0.564) 
1.447 
(0.293) 
Post2 -0.000 
(0.997) 
-0.006 
(0.468) 
-0.002 
(0.679) 
-0.003 
(0.792) 
0.002 
(0.718) 
1.858** 
(0.039) 
2.630** 
(0.028) 
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Chapter 3: Paper II 
 
Medicaid Expansion and Access to Care among Cancer Survivors: A Baseline Overview 
 
Abstract 
Purpose Medicaid expansion under the Affordable Care Act facilitates access to care among 
vulnerable populations, but 21 states have not yet expanded the program. Medicaid expansions 
may provide increased access to care for cancer survivors, a growing population with chronic 
conditions. We compare access to healthcare services among cancer survivors living in non-
expansion states to those living in expansion states, prior to Medicaid expansion under the 
Affordable Care Act. 
Methods We use the 2012 and 2013 Behavioral Risk Factor Surveillance System to perform 
multiple logistic regression models to compare inability to see a doctor because of cost, having a 
personal doctor, and receiving an annual checkup in the past year between cancer survivors who 
lived in non-expansion states and survivors who lived in expansion states. 
Results Cancer survivors in non-expansion states had statistically significantly lower odds of 
having a personal doctor (adjusted odds ratio [AOR] 0.77; 95 % confidence interval [CI] 0.64–
0.94; p<0.001) and higher odds of being unable to see a doctor because of cost (AOR 1.19, 95 % 
CI 1.03–1.38, p<0.05). Statistically significant differences were not found for annual checkups. 
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Conclusions Prior to the passage of the Affordable Care Act, cancer survivors living in 
expansion states had better access to care than survivors living in non-expansion states. Failure 
to expand Medicaid could potentially leave many cancer survivors without access to routine care.  
Implications for Cancer Survivors Existing disparities in access to care are likely to widen 
between cancer survivors in non-expansion and expansion states. 
Key words Medicaid expansion. Cancer survivors. Access to care. Disparities. 
Introduction 
Cancer survival is improving as a result of earlier detection of the disease and advances 
in treatment (Centers for Disease Control and Prevention, 2015). In 2014, there were 14.5 
million adults and children with a history of cancer living in the United States, and 
approximately 1.6 million new cases of cancer are estimated to be diagnosed in 2015 (American 
Cancer Society, 2014c). Given the high incidence and survival rates, cancer survivors consume a 
considerable amount of health care services (Erikson, Salsberg, Forte, Bruinooge, & Goldstein, 
2007). For example, they require oncology visits for cancer surveillance and follow-up care as 
well as primary care visits for routine care related to other health conditions, pain and other 
symptom control, and secondary malignancy screenings (Earle, Burstein, Winer, & Weeks, 
2003; Earle, 2006; Mayer et al., 2012; McCabe & Jacobs, 2012). However, many cancer 
survivors face financial problems that prevent them from receiving timely and recommended 
health care (Yabroff et al., 2013). A study using data from the National Health Interview Survey 
(NHIS) found that cancer survivors were more likely to delay care because of cost than the 
general population and among cancer survivors who reported financial difficulties, they were 
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more likely to delay or even give up medical care entirely (Kent et al., 2013; Weaver, Rowland, 
Bellizzi, & Aziz, 2010).  
The Institute of Medicine (IOM), the Centers for Disease Control and Prevention (CDC), 
and the American Society of Clinical Oncology (ASCO) recommend that each cancer survivor 
receive a survivorship care plan to facilitate follow-up care (American Society of Clinical 
Oncology, 2014; Centers for Disease Control and Prevention, 2014a). For example, ASCO 
recommends that breast cancer patients receive a physical examination every three to six months 
for the first three years following breast cancer treatment, every six to 12 months in the fourth 
and fifth years, and annually thereafter (American Society of Clinical Oncology, 2014). 
However, among uninsured and publicly insured individuals aged 18 to 64 years, cancer 
survivors are less likely to have a usual source of care and use preventive services than other 
individuals who were not diagnosed with cancer (Yabroff et al., 2013).  
While transitioning to survivorship, cancer patients may experience difficulties, such as 
lack of health insurance, low socioeconomic status, poor communication with primary care 
providers, and uncertainty about follow-up care (Dulko et al., 2013; Earle & Neville, 2004). 
These and other factors contribute to lack of coordinated care or even absence of care for 
disadvantaged patients (Steinberg, 2008). When older breast cancer survivors were asked how 
they could be helped to deal with the financial burden of cancer, they reported that they mostly 
needed financial assistance through public agencies and better health insurance with lower cost-
sharing (Pisu, Martin, Shewchuk, & Meneses, 2014).   
Prior to the Affordable Care Act (ACA), Medicaid provided health insurance coverage to 
certain groups of low-income people, including children, pregnant women, and disabled 
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individuals. Medicaid eligibility varied across states, but the program covered mandatory 
services such as laboratory services, family planning, prescription drugs, and inpatient and 
outpatient hospital services. In addition, states varied in their pre-ACA expansion experiences. 
Many states, such as Arkansas and Oregon received Section 1115 waivers to expand Medicaid 
eligibility to childless adults. These waivers were not only different in implementation year and 
duration, but also in their eligibility requirements, creating differences in generosity of Medicaid 
across states. For example, Massachusetts and Vermont were very generous, with eligibility 
thresholds higher than 200% of the federal poverty level (FPL), while Michigan’s threshold was 
below 100% FPL (Kaiser Family Foundation, 2013). 
Medicaid expansion under the ACA provides coverage for individuals, including 
childless adults, with income up to 138% of the FPL. Medicaid expansion will broadly cover 
preventive services, but narrowly cover prescription drugs (Paradise, June, 2014). Although 
Medicaid expansion aims to reduce the uninsurance rate, the debate continues as to whether 
Medicaid will improve access to care and use of services (Antos, 2013; Kaiser Family 
Foundation Medicaid and the Uninsured, 2012). While there is evidence of poorer outcomes 
among Medicaid enrollees than uninsured individuals in some domains, research shows an 
association between Medicaid coverage and improvement in access to care and health outcomes 
(Gottlieb, 2011). Compared to their low-income privately insured peers, Medicaid beneficiaries 
have comparable access to services such as doctor visits and preventive care (Coughlin et al., 
2005; Long et al., 2005). Medicaid expansion to adults prior to the Affordable Care Act (ACA) 
was associated with a reduction in all-cause mortality, an increase in insurance coverage, and a 
reduction in delayed care related to cost among older adults, nonwhite, and poor individuals 
(Sommers, Baicker, & Epstein, 2012). However, under the ACA, only 29 states and the District 
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of Columbia expanded Medicaid coverage to low-income childless adults (Garfield, Damico, 
Stephens, & Rouhani, 2014).  
Despite general agreement about the importance of receiving follow-up care for cancer 
survivors, little is known about the receipt of care among cancer survivors living in non-
expansion states compared to those living in expansion states (American College of Surgeons, 
2014; Balogh et al., 2011; Horning, 2008). Previous studies have focused on the type of provider 
seen by survivors, survivors’ perceptions of care options, personal barriers to receive care, 
challenges of providers, and qualitative studies to identify unmet needs of survivors (Dulko et 
al., 2013; Friese et al., 2014; Khan, Evans, & Rose, 2011; Mayer et al., 2012; McCabe & Jacobs, 
2012; Miedema & Easley, 2012; Pisu et al., 2014). No study to date has focused on the changes 
in Medicaid policies that influence care during the survivorship period.  
The purpose of this paper is to compare access to healthcare services among cancer 
survivors who reside in states that have not expanded Medicaid under the ACA and those who 
reside in states that expanded Medicaid, using data prior to the implementation of the ACA. We 
assess whether, at baseline, cancer survivors were unable to see a doctor because of cost, if they 
had a personal doctor, and if they received annual checkups in non-expansion states compared to 
expansion states. To rule out the effect of other potential factors affecting the association 
between residence in non-expansion or expansion states, we control for demographic 
characteristics, income, and insurance coverage. As nearly half of states debate Medicaid 
expansion, an understanding of pre-expansion access to care among cancer survivors can inform 
policy and clinical decisions. 
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Methods 
 
Data sources 
We use pooled cross sectional data from the 2012 and 2013 Behavioral Risk Factor 
Surveillance System (BRFSS). The BRFSS is a nationally representative annual survey that 
collects information on self-reported preventive health practices and risk behaviors. It is a 
random, population-based telephone survey of non-institutionalized adults in all 50 states and the 
District of Columbia (DC) (Centers for Disease Control and Prevention, 2013a). In addition to 
using BRFSS data, we use 2012 and 2013 information from the Department of Health and 
Human Services to construct a measure of income as a percentage of the FPL for each household 
in every year (U.S. Department of Health & Human Services, 2015). 
 
Study population 
 We restrict our analyses to cancer survivors who responded to the BRFSS survey during 
the study period. We define a cancer survivor as any individual aged 18 to 64 years who reports 
having been diagnosed with any type of cancer other than skin cancer. We use this age range 
because it allows for inclusion of adults who may be eligible for Medicaid coverage. We only 
include patients who reported to be diagnosed with any type of cancer and were never told to 
have skin cancer. We exclude survivors with skin cancer because this type of cancer is rarely life 
threatening and we did not have data on skin cancer for 2013. After this exclusion, we identified 
30,249 cancer survivors. We excluded observations with missing data on income (n=3,295), 
 
 
39 
 
checkup (n=261), inability to see a doctor because of cost (n=52), personal doctor (n=38), 
race/ethnicity (n=386), and missing data on education, employment, marital status, and insurance 
coverage (n=164). The sample used for the analysis consists of 26,053 cancer survivors. 
 
Dependent variables 
We use three self-reported dependent variables from the BRFSS health care access 
module, which contains questions about the ability of respondents to access health care services 
(Centers for Disease Control and Prevention, 2013b). The first two dependent variables are 
whether the respondent was unable to see a doctor because of cost and if the respondent reported 
having a personal doctor in the past year. The third outcome is related to utilization of preventive 
health care services and focuses on whether the respondent received an annual checkup in the 
past 12 months. 
 
Independent variables 
The independent variable of interest is residence in a non-expansion state. We classify 
states into two groups: non-expansion and expansion states. We define non-expansion states as 
those which have not decided to expand Medicaid under the ACA as of June, 2015. We obtained 
information on states’ Medicaid expansion from the Centers for Medicare and Medicaid Services 
(CMS) (Centers for Medicare and Medicaid Services, 2014). Additional covariates include 
demographic information (age, race, ethnicity, marital status, childlessness “not having children 
under 18 years old”) and socioeconomic status (income, education, employment status, insurance 
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coverage). Age is constructed as a categorical variable (18 –29 [reference group], 30– 39, 40– 
49, 50 –59, 60 –64 years). Race is a categorical variable of racial groups (white [reference 
group], African American, Asian, other). Ethnicity, marital status, and childlessness are binary 
variables. Income is a categorical variable (less than 138% of FPL [reference group], 138 – 
400% of FPL, more than 400% of FPL). Education is a categorical variable (less than high 
school [reference group], high school, some college, college or more). Employment and 
insurance status are binary variables. 
 
Statistical analysis 
We use multiple logistic regression models to compare differences in the outcome 
measures between cancer survivors living in non-expansion and expansion states. We generate 
adjusted odds ratios and 95% confidence intervals to compare the estimated differences in each 
outcome measure between cancer survivors living in non-expansion and expansion states. In 
addition to using the full sample (n=26,053), we repeat the analyses using a subsample 
consisting of low-income cancer survivors (n=8,862). Low-income survivors are most affected 
by changes in insurance status and are less likely to access care if they do not have affordable 
insurance (National Cancer Institute, 2008). We use survey weights in the analyses to control for 
the complex sampling design of the BRFSS survey, nonresponse, and telephone non-coverage 
rates among respondents in different states (Centers for Disease Control and Prevention, 2013a). 
All statistical analyses were conducted using Stata 12. 
 Because states are different in the generosity of their pre-ACA Medicaid eligibility, we 
repeated our analyses comparing states that had generous Medicaid eligibility (before the ACA) 
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with the same set of post-ACA non-expansion states. We defined generous states as those with 
Medicaid eligibility threshold equal to or higher than 200% FPL. We hypothesized that 
comparing these two groups would show larger differences in outcome measures between non-
expansion and generous eligibility states than the differences we obtained from the primary 
analysis when we compared non-expansion states with all post-ACA Medicaid expansion states. 
 
Results 
Table 8 reports descriptive statistics for cancer survivors for expansion and non-
expansion states. Significantly greater proportions of cancer survivors in non-expansion states 
were African American (15.8%), had household incomes lower than 138% FPL (46.1%), and 
had lower rates of insurance coverage (83.4%) than survivors residing in expansion states. 
Survivors residing in non-expansion states had a statistically significantly greater rate of inability 
to see a doctor in the past year because of cost (26.0% versus 21.1%, p< 0.001). In addition, 
survivors residing in non-expansion states were significantly less likely to report having a 
personal doctor (85.7% compared to 89.4%, p< 0.001), but had comparable probabilities of 
receiving annual checkups to survivors residing in expansion states. 
Tables 9 and 10 report results from the adjusted logistic regression analyses that assessed 
factors associated with access to and utilization of healthcare services for both the full sample 
and the low-income sample. Residing in a non-expansion state was positively and statistically 
significantly associated with inability to see a doctor because of cost in the full sample (adjusted 
odds ratio [AOR] 1.19; 95 % confidence interval [CI] 1.03–1.38; p<0.05) and (AOR 1.30; 95% 
CI 1.06–1.58, p<0.05) in the full sample and the low-income sample, respectively. Cancer 
 
 
42 
 
survivors residing in non-expansion states had statistically significantly lower odds for having a 
personal doctor in the past year (full sample AOR 0.77; 95% CI 0.64–0.94, p<0.001; low-income 
sample AOR 0.77, 95% CI 0.59–0.99, p<0.05). There was no statistically significant difference 
in the odds of receiving annual checkups in the full or the low-income sample. Further, annual 
household income was positively associated with having a personal doctor and receiving annual 
checkups and negatively associated with inability to see a doctor in the full sample. 
Table 11 reports the coefficients of the logit model for the three outcomes when we 
restricted our sample to survivors living in non-expansion states and states with generous 
eligibility prior to the ACA. The results show that cancer survivors residing in non-expansion 
states had statistically significantly lower odds (AOR 0.76, 95% CI 0.60–0.98, p<0.05) of having 
a personal doctor in the past year than survivors residing in states with generous eligibility. Low-
income survivors who live in non-expansion states had marginally statistically significantly 
higher odds of inability to see a doctor because of cost (AOR 1.26, 95% CI 0.98–1.61, p<0.10), 
lower odds of having a personal doctor (AOR 0.73, 95% CI 0.53–1.02, p<0.10), but higher odds 
of receiving annual checkups (AOR 1.25, 95% CI 0.97–1.61, p<0.10).  
 
Discussion 
We compared access to care, prior to Medicaid expansion under the ACA, among cancer 
survivors who live in states that expanded Medicaid and survivors who live in states that did not 
expand Medicaid under the ACA. In all analyses, we controlled for other factors that may affect 
access including demographic characteristics, income, and insurance coverage. Cancer survivors 
who live in non-expansion states were more likely to face financial barriers to see a doctor and 
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less likely to have a personal doctor than cancer survivors who live in expansion states. These 
findings were statistically significant in the full sample and the low-income sample. However, 
we did not find statistically significant differences in receiving annual checkups. 
While cancer survivors are at high risk of developing other cancers or experiencing late 
effects of treatment, our findings imply that survivors living in non-expansion states are less 
likely to access healthcare services, which are necessary to receive the care they need (American 
Cancer Society, 2014d; Hong, Nekhlyudov, Didwania, Olopade, & Ganschow, 2009; Ng & 
Travis, 2008). Our finding highlights a gap between non-expansion and expansion states prior to 
the ACA Medicaid expansions. These differences in access to care may exacerbate known 
disparities in non-expansion states. Uninsured non-elderly survivors are less likely to have a 
usual source of care or use preventive services than a similar group of privately insured survivors 
(Yabroff et al., 2013). When uninsured survivors fail to receive continuous care, they will be at 
high risk for adverse health events. Our findings inform the debate on Medicaid expansions by 
providing an important understanding of baseline access to care for cancer survivors in states that 
expanded Medicaid as of June 2015 and those who are still exploring the option of expanding the 
program. 
We did not observe statistically significant differences for receiving annual checkups, but 
instead found comparable rates among survivors living in expansion and non-expansion states. 
We can interpret this finding in different ways. A respondent could have been diagnosed with 
cancer in the past year and still be receiving treatment, alleviating the need for checkups or 
follow-up visits. Additionally, survivors may be vigilant about annual checkups and continue to 
receive care from their oncologists or other providers regardless of other barriers to access.  
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Several limitations must be acknowledged. Like other survey-based research, the 
analyses are based on self-reported data, creating concerns about validity and reliability. 
However, self-reported measures of preventive care in the BRFSS have been used in several 
previous studies that examined changes in Medicaid (Adams, Kenney, & Galactionova, 2013; 
Weissman, Zaslavsky, Wolf, & Ayanian, 2008; Wherry, 2013). To address concerns on self-
reported data, we used sampling weights to account for complex sampling design and correct for 
potential nonresponse biases (Centers for Disease Control and Prevention, 2014b). Another 
limitation is that the BRFSS data do not have information on Medicaid coverage. We used 
Medicaid eligibility threshold of 138% FPL to create the low-income sample that would be 
eligible for Medicaid. Last, as this study is specific to cancer survivors, it may not be 
generalizable to populations with other chronic conditions or acute illness.  
Medicaid expansion under the ACA aims to increase health insurance coverage for low-
income populations. While the original law intended that all the states expand Medicaid, the 
2012 decision of the Supreme Court gave each state the option to expand or not. Cancer 
survivors, like many other patients with chronic conditions, need regular care with a primary care 
provider to manage their health and receive follow-up screenings and tests (Earle, 2006; McCabe 
& Jacobs, 2012). Medicaid expansion provides insurance coverage for people with annual 
income lower than 138% of FPL. This study provides insight regarding the pre-existing 
differences in access to care before Medicaid expansion under the ACA. States that choose not to 
expand Medicaid could potentially leave many cancer survivors without access to routine 
healthcare services, exacerbating disparities between states. 
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Table 8: Descriptive statistics for cancer survivors sample by 2015 state Medicaid expansion 
status 
Characteristic  Expansion States 
(N= 15,478) 
Non-expansion States 
(N= 10,575) 
 
P Value 
Inability to see a doctor because of cost (%) 21.1 26.0 <0.001 
Having a personal doctor (%) 89.4 85.7 <0.001 
Annual checkup (%) 74.7 74.9  
Age group (%)    
  18– 29 years 7.8 7.3  
 
 
  30– 39 years 12.1 12.3 
  40– 49 years 19.1 20.1 
  50– 59 years 37.9 37.2 
  60– 64 years 23.1 23.0 
Sex (%)     
  Male 30.3 29.2  
   Female  69.7 70.8 
Race (%)    
  White 80.9 77.5  
   African American 9.3 15.8 
  Asian 4.5 1.5 
  Other race 5.3 5.2 
Ethnicity (%)    
  Hispanic 11.5 7.5  
<0.001   Non-Hispanic 88.5 92.5 
Marital status (%)    
  Married 54.0 56.7  
<0.05   Unmarried 46.0 43.3 
Education (%)    
  Less than high school 13.2 14.9  
<0.10 
 
  High school 27.7 27.4 
  Some college 34.3 34.8 
  College 24.7 22.9 
Income (%)    
  <138% of FPL 40.1 46.1  
<0.001   138–400% of FPL 42.9 39.0 
  >400% of FPL 17.0 14.9 
Employment (%)    
  Employed 54.0 52.3  
   Unemployed  46.0 47.7 
Insurance coverage (%)    
  Insured 87.1 83.4  
<0.001   Uninsured 12.9 16.6 
Childlessness (%)    
  Childless adult 65.7 65.0  
   Has dependent children 34.3 35.0 
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Table 9: Logistic regressions estimations of outcome measures on state Medicaid expansion status for Full sample (N= 26,053) 
 Cost 
Barrier 
OR 
95% CI Personal 
Doctor 
OR  
95% CI Checkup 
OR  
95% CI 
Expansion status (Expansion state reference category)       
  Non-expansion state 1.19** (1.03 - 1.38) 0.77***  (0.64 - 0.94) 1.07  (0.94 - 1.21) 
Household income (< 138% of FPL reference 
category) 
      
  >400% of FPL 0.18***  (0.13 - 0.23) 2.48***  (1.80 - 3.41) 1.54***  (1.26 - 1.88) 
  138-400% of FPL 0.41***  (0.35 - 0.49) 1.87*** (1.50 - 2.33) 1.19**  (1.01 - 1.39) 
Age (18- 29 years reference category)       
  Age 60-64 years 0.49***  (0.34 - 0.71) 4.08***  (2.84 - 5.86) 1.79***  (1.34 - 2.39) 
  Age 50- 59 years 0.71**  (0.52 - 0.99) 3.80***  (2.72 - 5.31) 1.46***  (1.11 - 1.93) 
  Age 40- 49 years 1.05  (0.75 - 1.46) 2.63***  (1.87 - 3.70) 1.37**  (1.05 - 1.80) 
  Age 30- 39 years 1.09  (0.77 - 1.55) 1.52**  (1.07 - 2.17) 1.08  (0.80 - 1.45) 
Gender (female reference category)       
  Male 0.74***  (0.61 - 0.89) 0.74***  (0.61 - 0.90) 0.99  (0.87 - 1.13) 
Race (White reference category)       
  African American 0.95  (0.76 - 1.20) 1.09  (0.81 - 1.48) 2.04***  (1.62 - 2.57) 
  Asian 1.36  (0.64 - 2.87) 1.04  (0.60 - 1.79) 1.21  (0.65 - 2.26) 
  Other race 1.08  (0.80 - 1.47) 0.73*  (0.51 - 1.05) 0.84  (0.63 - 1.13) 
Ethnicity (Non-Hispanic reference category)       
  Hispanic 0.91  (0.66 - 1.25) 0.95  (0.67 - 1.35) 1.30*  (0.99 - 1.71) 
Marital status (unmarried reference category)       
  Married 0.83**  (0.71 - 0.96) 1.24**  (1.01 - 1.52) 1.04  (0.91 - 1.18) 
Education (less than high school reference category)       
  College or more 0.58***  (0.44 - 0.75) 1.70***  (1.26 - 2.28) 1.00  (0.79 - 1.27) 
  Some college 0.83  (0.65 - 1.05) 1.65***  (1.24 - 2.20) 0.88  (0.70 - 1.10) 
  High school 0.85  (0.67 - 1.09) 1.24  (0.92 - 1.67) 1.01  (0.80 - 1.27) 
Employment (not employed reference category)       
  Employed 0.75***  (0.64 - 0.88) 0.73***  (0.60 - 0.89) 0.82***  (0.72 - 0.93) 
* p<0.10, **p<0.05, ***p<0.01 
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Table 9: Logistic regressions estimations of outcome measures on state Medicaid expansion status for Full sample (Continued). 
Insurance status (uninsured reference category)       
  Insured 0.14***  (0.12 - 0.17) 6.16***  (5.02 - 7.55) 3.86***  (3.26 - 4.56) 
Childlessness (has dependent children reference 
category) 
      
  Childless adult 1.28***  (1.07 - 1.54) 0.79**  (0.65 - 0.97) 1.02  (0.87 - 1.20) 
* p<0.10, **p<0.05, ***p<0.01 
 
 
Table 10: Coefficients of logistic regressions for the low-income sample (N= 8,862) 
 Cost 
Barrier 
OR 
95% CI Personal 
Doctor 
OR  
95% CI Checkup 
OR  
95% CI 
Expansion status (Expansion state reference category)       
  Non-expansion state 1.30**  (1.06 - 1.58) 0.77**  (0.59 - 0.99) 1.16  (0.95 - 1.41) 
* p<0.10, **p<0.05, ***p<0.01 
 
 
Table 11: Coefficients of logistic regressions for states with generous eligibility as a comparison group 
 Cost 
Barrier 
OR 
95% CI Personal 
Doctor 
OR  
95% CI Checkup 
OR  
95% CI 
Full sample (N= 14,175)       
Expansion status (Expansion state with generous 
eligibility reference category) 
      
  Non-expansion state 1.11  (0.92 - 1.30) 0.76**  (0.60 - 0.98) 1.08 (0.93 - 1.27) 
Low-income sample (N= 5,048)       
Expansion status (Expansion state with generous 
eligibility reference category) 
      
  Non-expansion state 1.26* (0.98 - 1.61) 0.73* (0.53 - 1.02) 1.25* (0.97 - 1.61) 
* p<0.10, **p<0.05, ***p<0.01 
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Chapter 4: Paper III 
 
The impact of generosity and duration of Medicaid expansion on access to healthcare 
services 
Abstract 
Objective To examine the effect of generosity and duration of Medicaid expansions on access to 
and utilization of preventive services among low-income adults. 
Data Sources/Study Setting 2012 Medical Expenditure Panel Survey (MEPS) – Household 
Component Full Year Consolidated File data. 
Study Design Multiple logistic models comparing outcomes among low-income people living in 
6 generous expansion, 6 moderate expansion, and 12 no-expansion states. 
Data Collection/Extraction Methods The analytic sample includes low-income non-elderly 
respondents ages 21–64 who live in one of the 24 states. 
Principal Findings Among low-income adults, moderate and generous Medicaid expansions 
were associated with significant increase in the probabilities of having Medicaid coverage, 
having a usual source of care, and having blood pressure checked in the past two years. Low-
income individuals living in states with longer durations of expansion were more likely to have 
better access to healthcare services than a similar group of individuals living in no-expansion 
states. 
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Conclusions While generosity alone was associated with more access to and utilization of health 
care services, the combination of generosity and longer duration of expansion intensified the 
association. The study informs policy makers that, relative to no expansion, moderate or 
generous expansion is associated with improvement in access to and utilization of healthcare 
services. It also provides evidence on the power of durability of the Medicaid program in 
improving access to and utilization of healthcare services. 
Key words: Medicaid expansions, generosity, duration, low-income, access, utilization 
 
Background 
The benefits of preventive health services are well established in the literature, indicating 
their importance in managing diseases and avoiding life-threatening illnesses (Maciosek, 
Coffield, Flottemesch, Edwards, & Solberg, 2010). Compared to insured individuals, uninsured 
people are less likely to access care and receive recommended preventive services (Buchmueller, 
Grumbach, Kronick, & Kahn, 2005; Devoe, Fryer, Phillips, & Green, 2003). Expanding 
Medicaid under the Affordable Care Act (ACA) is expected to be a key factor in increasing 
access to healthcare services for low-income individuals (McMorrow, Kenney, & Goin, 2014). 
Early evidence from implementation of the ACA shows improvement in access to care 
(Sommers, Gunja, Finegold, & Musco, 2015).    
Prior to the ACA, some states obtained Section 1115 waivers from the federal 
government and expanded Medicaid programs to low-income parents and childless adults who 
were not eligible to be covered by Medicaid under federal requirements (Centers for Medicare 
and Medicaid, 2014). Expansions in these states differed in their generosity (Medicaid eligibility 
thresholds) and year of implementation, creating variation in access to care among eligible 
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individuals across states that expanded Medicaid. For example, Indiana started its pre-ACA 
Medicaid expansion in 2008 with an eligibility threshold of 200% federal poverty level (FPL) 
while Arizona’s expansion was implemented in 2008 with a 100% FPL threshold.  
Access to care is not only affected by Medicaid policy, but also by the level of physician 
payment, which affects acceptance of Medicaid patients (S. L. Decker, 2012). While the goal of 
Medicaid expansions is to increase health insurance coverage for low-income people, physicians’ 
acceptance of these new patients remains an issue. Recent data show that the percentage of 
office-based physicians accepting Medicaid decreased from 73.5% during 1999–2000 to 64.5% 
in 2008–2009 (Centers for Disease Control and Prevention, 2011). Further, one third of 
physicians in 2011 reported that they would not accept new Medicaid patients but also stated that 
higher payments may increase their willingness to accept such patients (S. L. Decker, 2012). 
Medicaid-to-Medicare Physician Fee Index is a ratio of fees paid for physicians when they treat 
Medicaid patients relative to Medicare patients in each state (Kaiser Family Foundation, 2016). 
Previous research found that higher Medicaid fees are associated with increase in physician 
participation in Medicaid and thereby improve access to care among children. However, higher 
payments may slightly improve access to and use of care among adults and children (Brunt & 
Jensen, 2014; S. Decker, 2007; Hahn, 2013; Shen & Zuckerman, 2005).  
Previous studies confirmed the association between Medicaid coverage and access to and 
utilization of preventive services, but no study has examined the effect of generosity of Medicaid 
eligibility or the combination of generosity and duration on access to healthcare services 
(Finkelstein et al., 2012; Kaiser Family Foundation Medicaid and the Uninsured, 2013; Sommers 
et al., 2012). Here, we define generosity based on Medicaid eligibility threshold of coverage. We 
define states with generous expansion as those with eligibility threshold of 138% FPL or higher, 
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and states with moderate expansion as those with threshold less than 138% FPL. This study 
examines the effect of Medicaid generosity in covering low-income individuals on access to and 
utilization of healthcare services. In particular, we assess having Medicaid coverage, having a 
usual source of care, inability to get necessary medical care, receiving a checkup in the past year, 
and receiving a blood pressure checkup in the past two years for low-income individuals living 
in moderate or generous expansion states relative to those living in no-expansion states.  
 
Methods 
Data and Sample 
We use publicly available data from the 2012 Medical Expenditure Panel Survey (MEPS) 
– Household Component Full Year Consolidated File along with restricted MEPS information on 
states’ identifiers. MEPS is a nationally representative database of the U.S. population and 
includes information on healthcare expenditures, utilization, and access to care (Agency for 
Healthcare Research and Quality, 2009). The response rate was 56.3% in 2012. We obtain 
information on Medicaid generosity, years since expansion, and the 2012 Medicaid-to-Medicare 
Physician Fee Index from the Kaiser Family Foundation reports and personal communication 
with sources in different states (Kaiser Family Foundation, 2016). The analytic sample includes 
low-income nonelderly adults aged 18–64 who responded to the MEPS survey in the 24 MEPS 
states during 2012. We define low-income respondents as those who reported that their family 
income was poor (<100% FPL), near poor (100–150% FPL), or low-income (150–200% FPL) 
(Banthin JS & Selden TM, 2006). 
Dependent variables 
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Our dependent variables are access to and utilization of preventive services. Access to 
care includes Medicaid coverage, having a usual source of care, and inability to get necessary 
medical care. Utilization of preventive services includes receipt of annual checkup in the past 
year and evaluation of blood pressure within the past two years. 
Independent variables 
We use information on Medicaid expansion to classify the 29 large MEPS states based on 
threshold of the expanded program and year since expansion. We focus on federally funded 
expansions and exclude Connecticut, Pennsylvania, and Tennessee because they only had state-
funded programs. Based on Medicaid eligibility threshold, we classify states into generous (with 
threshold ≥ 138% FPL), moderate (with threshold <138% FPL), and no-expansion states. We 
exclude Colorado and Minnesota because their federally funded expansions started in 2012 (zero 
years of expansion relative to 2012). Excluding these states allows us to use 24 states in our 
analysis. Table 12 provides information on Medicaid generosity and years since expansion for 
the 24 states used in this study. 
We control for Medicaid-to-Medicare Physician Fee Index, a key factor in determining 
access to and utilization of healthcare services. High indices make physicians more likely to 
accept Medicaid patients, reducing one of the barriers to access healthcare services among low-
income individuals. Other independent variables include age, sex, race, ethnicity, marital status, 
education, employment, and number of MEPS priority conditions. 
Statistical Analysis 
We use multiple logistic regression models to assess the effect of the differences in 
Medicaid expansion on access to and utilization of healthcare services. We use level of 
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expansion (generous expansion, moderate expansion, no-expansion) as the main independent 
variable as shown in Equation (1): 
Logit (Y)  =  β0 + β1 ModerateExp + β2 GenerousExp + β3 Index + β4 Xs+ ϵ  (3) 
where Y is the dependent variable, defined as one of the access or utilization measures. 
ModerateExp is a binary variable equals to one for states with moderate expansion (threshold 
<138% FPL) and zero otherwise. GenerousExp is a binary variable equals to one for states with 
generous expansion (threshold ≥ 138% FPL) and zero otherwise. Index is a continuous variable 
for the 2012 Medicaid-to-Medicare Physician Fee Index for each state and Xs indicates the other 
control variables. Our first coefficient of interest is β1, which captures the difference in outcomes 
for low-income individuals living in moderate expansion states and a similar group of 
individuals living in states that did not expand Medicaid. Similarly, our second coefficient of 
interest is β2, capturing the differences in outcomes for low-income individuals living in 
generous expansion states relative to low-income individuals living in states that did not expand 
Medicaid. 
Next, we add years of expansion and interaction terms to control for duration of expansion in 
each state. YearsExpansion is a continuous variable obtained by subtracting year of expansion 
from 2012 (shown in Table 12).  
Logit (Y)  =  β0 + β1 ModerateExp + β2 GenerousExp + β3 Index + β4 ModerateExp * 
YearsExpansion + β5 GenerousExp * YearsExpansion + β6 Xs+ ϵ  (4) 
where, ModerateExp * YearsExpansion is an interaction term of Moderate expansion states and 
years since expansion, and GenerousExp * YearsExpansion is an interaction term of Generous 
expansion states and years since expansion. 
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We use survey weights in the analyses to control for the complex sampling design of the MEPS 
survey. All statistical analyses were conducted using Stata 12. 
 
Results 
Table 13 compares the characteristics for low-income individuals living in no-expansion, 
moderate, and generous expansion states in 2012. Just over half individuals live in no-expansion 
states (52%) while approximately 20% and 28% live in moderate and generous expansion states, 
respectively. In no-expansion states, the rate of Medicaid coverage is 19% while it is 33% in 
moderate and 29% in generous expansion states. The rates of having a usual source of care, 
receiving an annual checkup, and having blood pressure evaluated in the past two years are the 
lowest for low-income individuals living in no-expansion states compared to either moderate or 
generous expansion states. For example, the rate of having a usual source of care is 60, 73, and 
65% for low-income individuals living in no-expansion, moderate, and generous expansion 
states, respectively. Further, inability to get necessary medical care is the highest (9%) among 
low-income individuals living in no-expansion states compared to similar groups living in 
moderate (7%) or generous (4%) expansion states.   
Table 14 reports the association between Medicaid generosity and access to and 
utilization of healthcare services, controlling for Medicaid-to-Medicare Physician Index and 
demographic variables. Residing in moderate or generous expansion states was associated with 
more access to and utilization of healthcare services compared to residing in states with no-
expansion. Low-income individuals living in moderate expansion states had statistically 
significant higher odds for having Medicaid coverage (adjusted odds ratio [AOR] 1.88, 95 % 
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confidence interval [CI] 1.33–2.67, p<0.001) and having a usual source of care (AOR 1.99, 95 % 
CI 1.42–2.77, p < 0.001) than low-income individuals living in no-expansion states. Similarly, 
residing in generous expansion states was positively and statistically significantly associated 
with having Medicaid coverage (AOR 1.91, 95 % CI 1.32–2.75, p < 0.001) and a usual source of 
care (AOR 1.54, 95 % CI 1.13–2.11, p < 0.001). Further, low-income individuals living in 
generous expansion states had statistically significant lower odds for inability to get necessary 
medical care (AOR 0.46, 95 % CI 0.27–0.76, p < 0.001). Low-income individuals living in 
moderate expansion states also had lower odds for inability to get necessary medical care, but 
this result was insignificant (AOR 0.65, 95 % CI 0.37–1.15, p = 0.14). 
For utilization of preventive services, low-income individuals living in moderate 
expansion states had statistically significant higher odds for receiving annual checkup in the past 
year (AOR 1.92, 95 % CI 1.39–2.65, p < 0.001) and evaluation of blood pressure within the past 
two years (AOR 2.17, 95 % CI 1.43–3.29, p < 0.001) than low-income individuals living in no-
expansion states. In addition, low-income individuals living in generous expansion states had 
statistically significant higher odds for receiving evaluation of blood pressure within the past two 
years (AOR 2.15, 95 % CI 1.39–3.33, p < 0.001), but the result for receiving an annual checkup 
was not significant. 
Medicaid-to-Medicare Physician Fee Index was associated with marginally significant 
higher odds for having a usual source of care (AOR 2.58, 95 % CI 0.97–6.87, p < 0.1) and 
receiving evaluation of blood pressure within the past two years (AOR 3.09, 95 % CI 0.84–
11.35, p < 0.1). 
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Table 15 reports results from the logistic regression models controlling for Medicaid-to-
Medicare Physician Index, years since expansion, and demographics. To explain these findings 
and understand the effect of the combination of generosity and duration of expansion on access 
to care, we use the odds ratios of generosity of expansion in Table 15 to calculate the odds ratios 
of generosity during years (3, 6, and 9) of expansion for all of the outcomes (Table 16). We use 
these years because they represent a wide range of duration of expansion in the states included in 
our study. Results in Table 16 describe the implication of the estimates for the effect of years of 
expansion. There is a gradual decrease in inability to get necessary medical care with longer 
duration of expansion. The magnitude of other outcomes (except having a usual source of care 
and receiving a checkup in the past year in moderate expansion states) increases gradually with 
longer periods of expansion. After 6– 9 years of expansion, almost all moderate and generous 
expansions are associated with significant increases in access and utilization measures as shown 
in Table 16. Nonetheless, low-income individuals living in moderate expansion states experience 
a significant decrease in having a personal doctor. After nine years of expansion, low-income 
individuals living in moderate expansion states have statistically significant higher odds for 
having Medicaid coverage (AOR 2.17, 95 % CI 1.49–3.17, p<0.001), lower odds for inability to 
get necessary medical care (AOR 0.54, 95 % CI 0.29–0.99, p<0.05), and higher odds for having 
blood pressure evaluation in the past two years (AOR 2.17, 95 % CI 1.32–3.55, p<0.001) than 
low-income individuals living in no-expansion states. 
 
Discussion 
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We examined the differences in access to and utilization of healthcare services for low-
income individuals living in moderate and generous expansion states compared to those living in 
states that did not expand Medicaid before 2012. Low-income individuals living in moderate or 
generous expansion states were more likely to have access to and utilization of preventive 
services than those living in no-expansion states. We also examined the effect of duration of 
expansion on access to and utilization of healthcare services. Low-income individuals living in 
states with longer durations of expansion were more likely to have better access to healthcare 
services than a similar group of individuals living in no-expansion states. Our findings indicate 
that while generosity alone was associated with more access to and utilization of health care 
services, the combination of generosity and longer duration of expansion played an important 
role in facilitating access to and utilization of healthcare services.  
The positive association between Medicaid expansion and access to and utilization of 
healthcare services are consistent with previous research on the effect of pre-ACA expansions on 
improving Medicaid coverage and access to care among low-income adults (Baicker & 
Finkelstein, 2011; Coughlin, Long, Graves, & Yemane, 2006; Sommers et al., 2012). Low-
income individuals who gain Medicaid coverage are usually assigned to a primary care physician 
or a community clinic. Therefore, they have a usual source of care and are able to receive 
recommended services such as regular checkups and blood pressure evaluations. 
Our findings that longer duration of expansion was associated with gradual increases in 
access and utilization measures highlights the importance of durability of the Medicaid program 
in affecting access and utilization in the long run. Having a usual source of care declined over 
time may be attributed to the churning process (switching between losing and gaining Medicaid 
coverage due to changes in income and Medicaid eligibility as a result). Individuals who lose 
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their coverage may be more likely to be assigned to different physicians from those they used to 
see and therefore they do not have the same source of care. Our findings that inability to get 
necessary medical care in states with moderate expansion were only significant after 9 years of 
expansion may be related to the existence of factors other than Medicaid coverage. Medicaid 
enrollees may face other barriers that hinder their ability to access healthcare services including 
co-payments, inability to miss work, or possibly refusal of physicians to see Medicaid patients 
(S. L. Decker, 2012; Ku, 2005).  
Our study has a few limitations. First, the study only includes 24 states that received 
federal waivers and for which restricted data are available through the Agency for Healthcare 
Research and Quality (AHRQ). Therefore, the findings may not be generalized to the whole 
country. Nonetheless, states used in the study are considered among those that implemented 
relatively large Medicaid expansions prior to the ACA. Second, as other survey data, MEPS are 
self-reported data that may be inaccurate. AHRQ performs quality control checks to ensure 
reliability and accuracy of data before release (Call et al., 2008; U.S. Department of Health and 
Human Services, 2015). Finally, the sample size for low-income individuals living in moderate 
or generous expansion states is small, which may have caused insignificant results for some 
outcome measures. 
This study has important policy implications for states that have not yet decided on 
implementing Medicaid expansion. The study informs policy makers that, relative to no 
expansion, moderate or generous expansion is associated with better access to and utilization of 
preventive services. States deciding on Medicaid expansion under the ACA will be 
implementing a generous expansion (≥ 138% FPL) and will increase the likelihood that low-
income residents will have Medicaid coverage and a usual source of care for a few years after 
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expansion (as long as these people are eligible for the program). Further, this study supports the 
evidence on importance of higher payments for physicians who treat Medicaid patients and 
increase the probability of having a usual source of care. The study provides evidence on the 
importance of the combination of generosity and longer duration of the Medicaid program to 
improve access to and utilization of healthcare services. States that may reconsider Medicaid 
expansion under the ACA once the complete federal funding ends in 2017, may need to realize 
the power of durability of the Medicaid program to fulfill its goals of increasing access to and 
utilization of healthcare services for the low-income population. 
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Table 12: Classification of states available in MEPS (federally funded programs)7,8 
Generous expansion ≥138% FPL Moderate expansion <138% FPL No- 
expansion 
States 
State Eligibility 
threshold 
Expansion 
Years of 
this 
program 
Number of 
years 
since 
expansion 
(2012 – 
first year 
of 
expansion) 
State Eligibility 
threshold 
Expansion 
Years of 
this 
program 
Number of 
years 
since 
expansion 
(2012 – 
first year 
of 
expansion) 
 
CA 200 08–12 4 AZ 100 02–12 10 AL 
IN 200 08–12 4 CO 10 12–12 0 FL 
MA 200 00–12 12 MD 116 08–12 4 GA 
MN 250 12–12 0 MI 35 04–12 8 IL 
OK 185 06–07 6 NJ 24-100 11–12 1 KY 
 200 08–12  NY 100 02–12 10 LA 
OR 170 00–02 12 WA 133 11–12 1 MO 
 185 03–09     NC 
 201 10–12     OH 
WI 200 09–12 3    SC 
       TX 
      VA 
 
  
                                                          
7 Connecticut, Pennsylvania, and Tennessee are excluded because each had a state funded program. 
8 Colorado and Minnesota are excluded from the analysis because their expansions started in 2012. 
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Table 13: Descriptive statistics of sample by generosity of expansion (n= 3,032) as of 2012 
 No- 
expansion 
Moderate 
expansion 
Generous 
expansion 
N 1,580 599 853 
Medicaid coverage (%) 19.10 32.66 29.22 
Have a usual source of care (%) 60.42 72.91 64.71 
Unable to get necessary medical care (%) 8.59 7.09 4.46 
Received checkup in the past year (%) 52.36 67.20 53.98 
Blood pressure checked in the past two years (%) 81.28 89.02 85.67 
Index Mean (±SE) 0.64 (±.008) 0.52 (±.013) 0.53 (±.020) 
Years of Expansion relative to 2012 Mean (±SE) NA 6.77 (±.367) 5.39 (±.284) 
Age (%)    
21–29 28.06 25.03 26.41 
30–39 23.05 23.34 27.28 
40–49 22.45 22.03 21.63 
50–<65 26.45 29.60 24.68 
Male (%) 44.47 47.06 45.73 
Race (%)    
White 72.83 71.55 79.10 
African American 23.73 21.64 8.94 
Other 3.44 6.81 11.96 
Hispanic 24.34 20.97 42.63 
Married (%) 39.18 36.20 40.87 
Education (%)    
Less than high school 27.60 21.93 26.72 
High school 32.95 38.81 34.31 
Some college 29.24 25.33 25.70 
College or more 10.21 13.93 13.28 
Employed (%) 52.52 45.17 50.85 
Chronic diseases (%)    
0 comorbidity 44.92 40.88 48.32 
1 comorbidity 20.57 22.43 18.86 
2 comorbidities 11.78 14.80 11.39 
3+ comorbidities 22.73 21.89 21.42 
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Table 14: Adjusted odds ratios from multiple logistic regressions (model 3) for the outcome 
measures 
 
 
 
Medicaid 
coverage 
Have a usual 
source of care 
Unable to get 
necessary 
medical care 
Received 
checkup in 
the past year 
Blood pressure 
checked in the 
past two years 
Moderate 
expansion 
1.88*** 
(1.33 - 2.67) 
1.99*** 
(1.42 - 2.77) 
0.65 
(0.37 - 1.15) 
1.92*** 
(1.39 - 2.65) 
2.17*** 
(1.43 - 3.29) 
Generous 
expansion 
1.91*** 
(1.32 - 2.75) 
1.54*** 
(1.13 - 2.11) 
0.46*** 
(0.27 - 0.76) 
1.18 
(0.87 - 1.61) 
2.15*** 
(1.39 - 3.33) 
No-
expansion 
Ref. Ref. Ref. Ref. Ref. 
Index 0.19*** 
(0.07 - 0.52) 
2.58* 
(0.97 - 6.87) 
0.24 
(0.04 - 1.55) 
0.99 
(0.43 - 2.28) 
3.09* 
(0.84 – 11.35) 
Age 50–<65 0.54*** 
(0.35 - 0.84) 
2.31*** 
(1.63 – 3.29) 
0.82 
(0.42 - 1.63) 
1.72*** 
(1.27 - 2.35) 
1.03 
(0.68 - 1.55) 
Age 40–49 0.81 
(0.55 - 1.20) 
1.74*** 
(1.28 - 2.36) 
1.76 
(0.89 - 3.51) 
1.25 
(0.93 - 1.66) 
0.94 
(0.63- 1.42) 
Age 30–39 1.20 
(0.86 - 1.67) 
1.31** 
(1.05 - 1.64) 
1.04 
(0.57- 1.89) 
1.15 
(0.88 - 1.51) 
0.82 
(0.60 - 1.13) 
Age 21–29 Ref. Ref. Ref. Ref. Ref. 
Male 0.51*** 
(0.40 - 0.65) 
0.45*** 
(0.38 - 0.53) 
0.53*** 
(0.34 - 0.84) 
0.54*** 
(0.46 - 0.64) 
0.30*** 
(0.23 - 0.39) 
Female Ref. Ref. Ref. Ref. Ref. 
African 
American 
1.48** 
(1.08 - 2.02) 
0.90 
(0.66 - 1.23) 
0.54** 
(0.32 - 0.93) 
1.79*** 
(1.41 - 2.29) 
1.31 
(0.91 - 1.89) 
Other 1.17  
(0.72 - 1.92) 
1.19 
(0.69 - 2.07) 
1.11 
(0.51 - 2.41) 
1.50* 
(0.92 - 2.47) 
1.16 
(0.60 - 2.26) 
White Ref. Ref. Ref. Ref. Ref. 
Hispanic 0.73** 
(0.53 - 0.99) 
0.62*** 
(0.46 - 0.84) 
0.41*** 
(0.23 - 0.71) 
0.96 
(0.68 - 1.36) 
0.55*** 
(0.37 - 0.84) 
Non-
Hispanic 
Ref. Ref. Ref. Ref. Ref. 
Married 0.49*** 
(0.37 - 0.64) 
1.37*** 
(1.09 - 1.73) 
0.65* 
(0.41 - 1.03) 
1.16 
(0.93 - 1.44) 
1.15 
(0.87 - 1.51) 
Unmarried Ref. Ref. Ref. Ref. Ref. 
College or 
more 
0.28*** 
(0.17 - 0.45) 
1.61** 
(1.10 - 2.36) 
0.79 
(0.35 - 1.78) 
2.19*** 
(1.58 - 3.04) 
1.92** 
(1.10 - 3.35) 
Some college 0.51*** 
(0.37 - 0.71) 
1.31* 
(0.98 - 1.76) 
0.97 
(0.54 - 1.77) 
1.51*** 
(1.11 - 2.06) 
1.73*** 
(1.23 - 2.44) 
High school 0.77** 
(0.60 - 0.98) 
1.22 
(0.93 - 1.59) 
0.85 
(0.47 - 1.51) 
1.30** 
(1.03 - 1.63) 
1.10 
(0.82 - 1.48) 
Less than 
high school 
Ref. Ref. Ref. Ref. Ref. 
Employed 0.36*** 
(0.27 - 0.48) 
0.86 
(0.71 - 1.05) 
0.78 
(0.51 - 1.21) 
0.73*** 
(0.60 - 0.89) 
0.87 
(0.67 - 1.13) 
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Unemployed Ref. Ref. Ref. Ref. Ref. 
3+ 
comorbidities 
3.99*** 
(2.69 - 5.92) 
3.92*** 
(2.80 - 5.50) 
3.26*** 
(1.67 - 6.37) 
4.72*** 
(3.34 - 6.68) 
14.05*** 
(7.20 - 27.43) 
2 
comorbidities 
1.96*** 
(1.34 - 2.86) 
2.20*** 
(1.56 - 3.11) 
3.96*** 
(1.98 - 7.95) 
2.39*** 
(1.74 - 3.28) 
4.31*** 
(2.72 - 6.83) 
1 
comorbidity 
1.24 
(0.88 - 1.75) 
1.70*** 
(1.31 - 2.21) 
1.87** 
(1.01 - 3.44) 
1.54*** 
(1.17 - 2.04) 
1.63*** 
(1.14 - 2.33) 
0 
comorbidity 
Ref. Ref. Ref. Ref. Ref. 
* p<0.10, **p<0.05, ***p<0.01 
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Table 15: Adjusted odds ratios from multiple logistic regressions (model 4) for the outcome 
measures 
 Medicaid 
coverage 
Have a usual 
source of 
care 
Unable to get 
necessary 
medical care 
Received 
checkup in 
the past year 
Blood pressure 
checked in the 
past two years 
Moderate 
expansion*Year 
1.12*** 
(1.05 - 1.20) 
0.94 
(0.88 - 1.01) 
0.93 
(0.83 - 1.04) 
1.00 
(0.92 - 1.07) 
1.01 
(0.92 - 1.10) 
Generous 
expansion*Year 
1.17*** 
(1.07 - 1.29) 
1.14** 
(1.02 - 1.27) 
0.94 
(0.81 - 1.09) 
1.05 
(0.96 - 1.15) 
1.05 
(0.91 - 1.21) 
No-
expansion*Year 
Ref. Ref. Ref. Ref. Ref. 
Moderate 
expansion 
0.77 
(0.44 - 1.37) 
2.77*** 
(1.47 – 5.24) 
1.04 
(0.41 - 2.61) 
1.92** 
(1.01 - 3.63) 
2.05** 
(1.07 - 3.93) 
Generous 
expansion 
0.74 
(0.39 - 1.41) 
0.74 
(0.40 - 1.40) 
0.62 
(0.23 - 1.72) 
0.89 
(0.49 - 1.60) 
1.70 
(0.72 - 4.04) 
No-expansion Ref. Ref. Ref. Ref. Ref. 
Index 0.10*** 
(0.04 - 0.29) 
1.33 
(0.51 - 3.48) 
0.23 
(0.03 - 1.80) 
0.78 
(0.30 - 2.03) 
2.65 
(0.65 - 10.71) 
Age 50–<65 0.54*** 
(0.34 - 0.85) 
2.28*** 
(1.60 – 3.23) 
0.81 
(0.41 - 1.60) 
1.72*** 
(1.26 - 2.34) 
1.03 
(0.68 - 1.55) 
Age 40–49 0.83 
(0.56 - 1.23) 
1.72*** 
(1.27 - 2.33) 
1.74 
(0.88 - 3.46) 
1.24 
(0.93 - 1.66) 
0.94 
(0.63 - 1.41) 
Age 30–39 1.21 
(0.87 - 1.68) 
1.32** 
(1.05 - 1.65) 
1.05 
(0.57 - 1.92) 
1.16 
(0.88 - 1.52) 
0.82 
(0.60 - 1.13) 
Age 21–29 Ref. Ref. Ref. Ref. Ref. 
Male 0.51*** 
(0.40 - 0.64) 
0.44*** 
(0.37 - 0.52) 
0.52*** 
(0.34 - 0.82) 
0.54*** 
(0.45 - 0.64) 
0.30*** 
(0.23 - 0.39) 
Female Ref. Ref. Ref. Ref. Ref. 
African 
American 
1.50** 
(1.10 - 2.06) 
0.92 
(0.67 - 1.25) 
0.55** 
(0.32 - 0.94) 
1.81*** 
(1.42 - 2.30) 
1.31 
(0.91 - 1.89) 
Other 1.20 
(0.73 - 1.96) 
1.19 
(0.69 - 2.05) 
1.09 
(0.50 - 2.38) 
1.51* 
(0.93 - 2.46) 
1.15 
(0.59 - 2.25) 
White Ref. Ref. Ref. Ref. Ref. 
Hispanic 0.75* 
(0.55 - 1.02) 
0.61*** 
(0.46 - 0.82) 
0.40*** 
(0.23 - 0.70) 
0.96 
(0.68 - 1.36) 
0.55*** 
(0.37 - 0.84) 
Non-Hispanic Ref. Ref. Ref. Ref. Ref. 
Married 0.48*** 
(0.36 - 0.62) 
1.38*** 
(1.10 - 1.74) 
0.66* 
(0.41 - 1.05) 
1.16 
(0.93 - 1.44) 
1.14 
(0.86 - 1.51) 
Unmarried Ref. Ref. Ref. Ref. Ref. 
College or more 0.25*** 
(0.15 - 0.41) 
1.54** 
(1.05 - 2.28) 
0.80 
(0.36 - 1.80) 
2.14*** 
(1.54 – 2.99) 
1.90** 
(1.08 - 3.33) 
Some college 0.51*** 
(0.37 - 0.70) 
1.29* 
(0.97 - 1.72) 
0.96 
(0.53 - 1.75) 
1.50* 
(1.10 - 2.05) 
1.73*** 
(1.23 - 2.44) 
High school 0.74** 
(0.58 - 0.96) 
1.21 
(0.92 - 1.58) 
0.85 
(0.48 - 1.51) 
1.29** 
(1.02 - 1.63) 
1.10 
(0.81 - 1.48) 
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Less than high 
school 
Ref. Ref. Ref. Ref. Ref. 
Employed 0.35*** 
(0.26 - 0.48) 
0.88 
(0.72 – 1.07) 
0.79 
(0.51 - 1.21) 
0.73*** 
(0.60 - 0.89) 
0.87 
(0.67 – 1.14) 
Unemployed Ref. Ref. Ref. Ref. Ref. 
3+ 
comorbidities 
3.90*** 
(2.62 - 5.81) 
3.95*** 
(2.81 - 5.53) 
3.35*** 
(1.71 - 6.58) 
4.69*** 
(3.31 - 6.63) 
13.95*** 
(7.15 - 27.21) 
2 comorbidities 1.98*** 
(1.34 - 2.93) 
2.17*** 
(1.53 - 3.07) 
3.91*** 
(1.94 - 7.90) 
2.38*** 
(1.74 - 3.25) 
4.28*** 
(2.70 - 6.77) 
1 comorbidity 1.24 
(0.88 - 1.75) 
1.71*** 
(1.32 - 2.22) 
1.86** 
(1.01 - 3.43) 
1.54*** 
(1.16 - 2.04) 
1.63*** 
(1.14 - 2.32) 
0 comorbidity Ref. Ref. Ref. Ref. Ref. 
* p<0.10, **p<0.05, ***p<0.01 
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Table 16: Adjusted odds ratios from multiple logistic regressions (model 4) for the outcome measures after 0, 3, 6, and 9 years of 
expansiona 
Years 
since 
expansion 
Medicaid coverage Have a usual source of 
care 
Unable to get necessary 
medical care 
Received checkup in the 
past year 
Blood pressure checked 
in the past two years 
 Moderate 
Expansion 
Generous 
Expansion 
Moderate 
Expansion 
Generous 
Expansion 
Moderate 
Expansion 
Generous 
Expansion 
Moderate 
Expansion 
Generous 
Expansion 
Moderate 
Expansion 
Generous 
Expansion 
0 0.77 
(0.44–1.37) 
0.74 
(0.39–1.41) 
2.77*** 
(1.47–5.24) 
0.74 
(0.40–1.40) 
1.04 
(0.41–2.61) 
0.62 
(0.23–1.72) 
1.92** 
(1.01–3.63) 
0.89 
(0.49–1.60) 
2.05** 
(1.07–3.93) 
1.70 
(0.72–4.04) 
3 1.09 
(0.72–1.66) 
1.20 
(0.77–1.86) 
2.32*** 
(1.45–3.70) 
1.10 
(0.75–1.61) 
0.83 
(0.42–1.65) 
0.52* 
(0.26–1.02) 
1.90*** 
(1.20–3.00) 
1.03 
(0.70–1.51) 
2.09*** 
(1.29–3.38) 
1.95** 
(1.14–3.33) 
6 1.54** 
(1.09–2.17) 
1.94*** 
(1.37–2.75) 
1.94*** 
(1.37–2.75) 
1.62*** 
(1.17–2.23) 
0.67 
(0.39–1.16) 
0.43*** 
(0.26–0.73) 
1.88*** 
(1.34–2.63) 
1.19 
(0.87–1.63) 
2.13*** 
(1.41–3.22) 
2.23*** 
(1.42–3.50) 
9 2.17*** 
(1.49–3.17) 
3.15*** 
(2.02–4.90) 
1.63*** 
(1.16–2.28) 
2.39*** 
(1.43–3.99) 
0.54** 
(0.29–0.99) 
0.36*** 
(0.18–0.71) 
1.85*** 
(1.31–2.62) 
1.38 
(0.89–2.14) 
2.17*** 
(1.32–3.55) 
2.55*** 
(1.26–5.14) 
a Results for 0 years of expansion are the adjusted odds ratios for moderate and generous expansion states from Table 15 
* p<0.10, **p<0.05, ***p<0.01 
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Chapter 5: Conclusion  
 
Medicaid expansion is one of the major provisions of the ACA, however, changes in 
Medicaid eligibility and other policies are not new to the Medicaid program. There have been 
different types of expansions prior to the ACA. In this study, I focused on the influence of 
Medicaid expansions (or contractions) on access to and utilization of healthcare services among 
the low-income population. This is an important policy issue that affects public health. 
This study explored three research questions: 1) what is the impact of Medicaid 
disenrollment in Tennessee on disparities in stage at diagnosis and surgery for breast cancer; 2) 
how does access to care for cancer survivors compare at baseline in states that did not expand 
Medicaid and those that expanded Medicaid under the ACA; and 3) what is the impact of 
generosity and duration of Medicaid expansion on access to healthcare services. The study used 
Tennessee Cancer Registry data from 2002–2008, SEER data, 2012 and 2013 BRFSS data, and 
2012 MEPS data. It used econometric models to test seven hypotheses. 
The study findings suggested that women living in low-income zip codes were more 
likely to be diagnosed at late stage of breast cancer compared to women living in high income 
zip codes after Medicaid disenrollment. The findings also suggest that cancer survivors living in 
expansion states were more likely to have better access to care than survivors living in non-
expansion states. Further, low-income individuals living in states with longer durations of 
expansion were more likely to have better access to healthcare services than a similar group of 
individuals living in no-expansion states. 
 
 
68 
 
The study has important policy implications. Our findings are important for states that 
may scale back Medicaid expansion due to changes in the state government (similar to the 
current discussion after the change of governor in Kentucky). In addition, existing disparities in 
access to care are likely to widen between cancer survivors in non-expansion and expansion 
states. Finally, durability of the Medicaid program improves access to and utilization of 
healthcare services. The dissertation findings present new opportunities for future research, 
including the effects of Medicaid contractions on other health outcomes and diseases. 
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Appendix I 
 
 
1. Exclusion of elderly people and those who were diagnosed at death 
The data contain 74,292 observations of women who were diagnosed with female breast 
cancer from 2000 – 2010 for all ages. We exclude 421 observations that were diagnosed at death, 
8 observations who were young (< 21 years old), 12 observations who were above 99 years old, 
and 28,167 observations who were 65 years or older. With these exclusions, we have a sample of 
45,684 of women diagnosed of breast cancer and their ages ranged between 21 and 64. 
2. Incomplete dates 
Since date of diagnosis have incomplete data (missing day and month or day only), we 
assume that the missing day in dates that have years and months only is the 15th of the month for 
352 observations. We compare the number of observations missing date of surgery with those 
missing date of most definitive surgery and find that most of the observations (4,834) that have 
missing data on date of surgery have also missing data on date of most definitive surgery.  
We exclude 96 observations that have year only for date of diagnosis (missing day and 
month). We replace 19 observations of dates of surgery that have month and year only with dates 
of most definitive surgery that have complete dates. We also replace two observations of date of 
primary surgery that have month and year only with date of most definitive surgery that have 
month and year only (date of most definitive surgery is more accurate). We also replace two 
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observations of dates of surgery that have year only with complete dates from most definitive 
surgery. For 133 observations that are missing day only in date of surgery of primary site, we 
assume that day to be the 15th of the month. We also replace 23 dates of treatment based on CoC 
that are missing day with complete dates from treatment based on SEER. We replace two dates 
of treatment based on CoC that have missing data with complete dates from treatment based on 
SEER. We replace 11 observations of dates of treatment CoC that have missing data with 
complete dates of treatment SEER. For 367 observations that have missing days of dates of 
treatment CoC, we assume the missing days to be the 15th of the month. 
3. Create new variables for date of surgery and treatment 
While we wanted to use date of most definitive surgery instead of date of surgery of 
primary site, we could not because date of most definitive surgery had data with large number of 
missing values. We create a new variable for date of surgery from date of surgery of primary 
site, but replace it with dates of most definitive surgery in specific cases where dates of most 
definitive surgery should be used. For example, we use date of most definitive surgery in 23 
observations when patients had resection. In addition, we use date of most definitive surgery for 
18 observations when date of surgery of primary site took place before date of most definitive 
surgery because the second operation is usually the most definitive. Furthermore, we use date of 
most definitive surgery for 2,302 observations when date of surgery of primary site was the same 
as date of diagnosis because that same date could have been surgical and diagnostic at the same 
time. We exclude 55 observations with year only date of surgery, and 64 observations with year 
only date of treatment. We use date of treatment CoC as the date of initiation of treatment. 
4. Create a variable indicating first line of treatment 
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We create a variable to indicate whether surgery is the first and only line of treatment, if 
treatment is first, and if surgery is first and is followed by another treatment. We use the new 
date of surgery to create a new variable for time to surgery (new date of surgery – date of 
diagnosis), and similarly, we use the new date of treatment to create time to treatment (date of 
treatment – date of diagnosis). We exclude 76 observations with date of surgery preceding date 
of diagnosis, and 24 observations with date of treatment preceding date of diagnosis. 
We consider time to surgery or treatment an outlier if it exceeds 365 days. We create a 
variable that categorizes the number of comorbidities into 0, 1, 2, 3 or more. We considered 
whether time to treatment exceeding 365 days is associated with higher numbers of 
comorbidities, but that was not the case. (For example, when we compared those who had more 
than 365 days delay in surgery, we found that 77 of them had no comorbidities, 19 had one 
comorbidity, 14 had two comorbidities, and 19 had three comorbidities or more). We decided to 
exclude 129 and 38 observations with time to surgery or treatment more than 365 days, 
respectively. With these exclusions, we have a sample of 45,202 observations. 
5. Zip codes 
We use zip code median income data (2006 - 2011 release) from the Population Studies 
Center at University of Michigan. When we compare the zip codes in the Tennessee Cancer 
Registry data with those from the Population Center, we find that there are 134 zip codes (595 
observations) that existed in the TN data but not in the income data. We use a free zip code 
database and found that the zip codes that were missing income data were P.O. Box zip code 
numbers, so they didn’t represent actual zip codes (United States Zip Codes, 2014). We drop 
these 595 observations and merged our data using the zip code median income data. While 
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44,600 observations are matched, 24 observations are not matched. These include 7 observations 
from the Tennessee data and 17 observations from the median income data. We drop the 24 non-
matched observations and, at this point, the sample includes 44,600 observations from 2000–
2010. 
6. Analytical sample 
We restrict our sample to three years before (2002 – 2004) and three years after (2006 – 
2008) Medicaid disenrollment, so we exclude 20,599 observations from the other years. From a 
sample of 24,001, we exclude 461 observations with unknown or missing data on stage at 
diagnosis, 2,305 observations with missing data on time to surgery, 2,114 observations with 
missing data on ethnicity, and 21 observations with missing time to treatment. We do not have 
missing data on race, age, or comorbidities. Our final sample consists of 19,100 observations 
with no missing data. 
We reviewed the poverty guidelines for 2002 – 2008 from the Department of Health and 
Human Services (HHS) and found that the median income of poverty over these years was 
$19,350 (it is also the income based on the poverty guideline in 2005 when disenrollment 
happened). We  use 200% of this poverty guideline (2 * $19,350= $38,700) as a threshold to 
stratify zip codes into high and low-income zip codes (we created a binary variable which equals 
1 for zip codes with median income below $38,700 and 0 for zip codes with median income 
above this threshold). 
We create a binary variable for more than 60 days delay in surgery and another binary 
variable for more than 90 days delay in surgery. Similarly, we create two binary variables one for 
more than 60 days delay in treatment and the other for more than 90 days delay in treatment. 
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We create a sample with no missing data for women aged 21– 64 who were diagnosed with 
breast cancer and lived in Tennessee from 2002– 2008.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
Flow Chart of our exclusion criteria 
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